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ABSTRACT 
INTRAVENOUS ACETEMINOPHEN REDUCES OPIOD USE FOR 
POSTOPERATIVE PAIN IN OBESE PATIENTS UNDERGOING 
LAPAROSCOPIC CHOLECYSTECTOMY  
by Kimberly Shae Burks 
December 2015 
Opioid-induced respiratory depression is categorized as a sentinel event, which is 
an unanticipated occurrence that may result in severe injury or death.  Although the 
incidence of opioid-induced respiratory depression is 0.2 to 2%, this issue persists as a 
substantial basis of morbidity and mortality.  The obese population has multiple 
physiologic elements that increase their risk for opioid-induced respiratory depression.  
This retrospective study examined if intravenous (IV) acetaminophen reduces opioid 
consumption in the postoperative period in obese patients who underwent a laparoscopic 
cholecystectomy.  Adequately controlled postoperative pain provides for greater patient 
satisfaction, decreased hospital length of stay (LOS), and reduced costs for the medical 
facility.  The inclusion criterion comprised patients within the ages of 18 to 65, a body 
mass index (BMI) greater than 30, and those who underwent a laparoscopic 
cholecystectomy at the designated medical facility.  Exclusion criteria included patients 
with a known allergy to acetaminophen, severe hepatic impairment, chronic alcoholism 
or use of opioids, and malnutrition; severe hypovolemia, or renal impairment.  The 
independent group t-test was used to compare the (a) amount of opioids administered in 
the post anesthesia care unit (PACU), (b) amount of opioids administered for the entire 
LOS, and (c) LOS between the two groups.  There was a significant difference found in 
  iii 
all of these factors.  A considerable finding of this capstone project was the mean cost for 
patients who received IV acetaminophen was $1,143.60, compared to $1,406.00 for those 
who did not receive IV acetaminophen.  This price difference was due to the variance in 
the total LOS. 
 
  
COPYRIGHT BY 
KIMBERLY SHAE BURKS 
2015
  
INTRAVENOUS ACETAMINOPHEN REDUCES OPIOID USE FOR 
POSTOPERATIVE PAIN IN OBESE PATIENTS UNDERGOING 
LAPAROSCOPIC CHOLECYSTECTOMY 
by 
Kimberly Shae Burks 
A Capstone Project 
Submitted to the Graduate School 
and the Department of  Advanced Practice  
at The University of Southern Mississippi 
in Partial Fulfillment of the Requirements 
for the Degree of Doctor of Nursing Practice 
Approved: 
________________________________________________ 
Dr. Vickie L. Stuart, Committee Chair 
Assistant Professor, Advanced Practice 
________________________________________________ 
Dr. J. Lachel Story, Committee Member 
Associate Professor, Systems Leadership and Health Outcomes 
________________________________________________ 
Dr. Bonnie L. Harbaugh, Committee Member 
Professor, Systems Leadership and Health Outcomes 
________________________________________________ 
Dr. Karen S. Coats 
Dean of the Graduate School 
 
 
 
December 2015 
 iv 
 
DEDICATION 
I would like to sincerely thank my parents, Jean and Randy Blakeney, and 
grandparents, Charles and Thelma Waltman, for instilling in me the determination to 
achieve anything I put my mind to.  To my sisters, Krystal Pollard and Karen McAlpin, 
thank you for your conviction and assurance in my abilities to accomplish this dream.  I 
would like to also thank the rest of my family for their patience and encouragement while 
completing this capstone project.  I would like to thank most of all our Lord, Jesus Christ, 
for his love and guidance. 
This capstone project is dedicated to my mother, Jean Blakeney, who has shown 
unwavering love and support in all I have attempted and accomplished throughout my 
life. 
  
 v 
 
ACKNOWLEDGMENTS 
I would like to thank my committee chair, Dr. Vickie Stuart, for all her assistance.  
I would also like to thank my committee member, Dr. Bonnie Harbaugh, for her valuable 
input and advice.  In addition, I would like to extend my sincerest gratitude to my 
committee member, Dr. Lachel Story, for her additional support in all research related 
items and statistical analysis.  Furthermore, I would also like to acknowledge Dr. James 
T. Johnson for assisting me with the statistical analysis.  I could not have completed this 
capstone project without each one of you. 
  
 vi 
 
TABLE OF CONTENTS 
ABSTRACT ....................................................................................................................... ii 
DEDICATION .................................................................................................................. iv 
ACKNOWLEDGMENTS ................................................................................................. v 
LIST OF TABLES .......................................................................................................... viii 
LIST OF ILLUSTRATIONS ............................................................................................ ix 
LIST OF ABBREVIATIONS ............................................................................................ x 
CHAPTER 
I. INTRODUCTION ..................................................................................... 1 
Clinical Question  
Problem Statement 
Purpose of the Project 
Background and Significance 
Conclusion 
II. REVIEW OF LITERATURE .................................................................. 16 
Intravenous Acetaminophen for the Reduction of Postoperative Pain 
Multimodal Therapy 
Opioid-Related Adverse Drug Events 
Needs Assessment 
Conceptual Framework 
DNP Essentials 
Evaluation Plan 
Assumptions 
Conclusion 
III. METHODOLOGY .................................................................................. 32 
Setting 
Population 
Sampling 
Target Outcomes 
Barriers 
Research Strategies 
Methods 
Statistical Analysis 
 vii 
 
Significance and Implications 
Conclusion 
 
IV. ANALYSIS OF DATA............................................................................ 40 
Discussion of Results 
Cost Analysis 
Conclusion 
V. SUMMARY ............................................................................................. 53 
Limitations 
Benefits 
Future Directions 
Conclusion 
APPENDIXES ................................................................................................................. 56 
REFERENCES ................................................................................................................ 89 
  
 viii 
 
LIST OF TABLES 
Table 
1.  Acetaminophen route comparison ........................................................................ 10 
2. Opioid receptors and their effects ......................................................................... 13 
3.  Patient demographics ............................................................................................ 41 
4.  Anesthesia and IV acetaminophen times .............................................................. 43 
5.  Total anesthesia time, hydromorphone given in PACU, and total PACU time .... 45 
6. Adverse events during and after PACU ................................................................ 47 
7. Discharge status, total Dilaudid, and total LOS .................................................... 48 
8. Cost analysis ......................................................................................................... 50 
  
 ix 
 
LIST OF ILLUSTRATIONS 
Figure 
1.  Mississippi and U.S. obesity rates over time ........................................................ 5 
  
 x 
 
LIST OF ABBREVIATIONS 
AACN American Association of the College of Nursing 
ADE Adverse drug events 
APSF Anesthesia Patient Safety Foundation 
BB beta blocker 
BMI body mass index 
CAD coronary artery disease 
CDC Centers for Disease Control and Prevention 
CI confidence interval 
CNS Central nervous system 
CO2 Carbon dioxide 
COPD Chronic obstructive pulmonary disease 
CXR chest radiograph 
D/C discharge 
DHHS Department of Health and Human Services 
DL direct laryngoscopy 
DM diabetes mellitus 
DVT Deep vein thrombosis 
EBL estimated blood loss 
EKG electrocardiograph 
eMAR electronic medication administration record 
EMR Electronic medical record 
ETT endotracheal tube 
 xi 
 
FDA Food and Drug Administration 
FRC Functional residual capacity 
GA general anesthesia 
GI Gastrointestinal 
HITECH Health Information Technology for Economic and Clinical Health 
HTN hypertension 
ICU Intensive care unit 
IV Intravenous 
IVF intravenous fluid 
LOS Length of stay 
ME Morphine equivalent 
Mcg microgram 
mg milligram 
ml milliliter 
MI Myocardial infarction 
MP mallampati classification 
NSAID Nonsteroidal anti-inflammatory drug 
N/V nausea and vomiting 
O2 oxygen 
OA osteoarthritis 
ORADE Opioid related adverse drug event 
OSA Obstructive sleep apnea 
PaCO2 Partial pressure of carbon dioxide 
 xii 
 
PACU Postanesthesia care unit 
PE Pulmonary embolism 
PEN patient encounter number 
PICO Problem, Intervention, Comparison, Outcome 
PID Pain intensity difference 
PIN patient identification number 
PMH personal medical history 
PNA Pneumonia 
PNB Peripheral nerve block 
PONV Postoperative nausea and vomiting 
TKA Total knee arthroplasty 
TOF train of four 
U.S. United States of America 
VAS Visual Analog Scale 
VS vital signs 
V/Q Ventilation/Perfusion 
X2 Chi Square test 
δ Delta 
Κ Kappa 
Μ Mu 
  
1 
 
CHAPTER I 
INTRODUCTION 
The management of postoperative pain is essential to many aspects of the healing 
process after an invasive surgical procedure.  The opioid class of pain medication has and 
continues to be the drug of choice for the relief of pain in the perioperative setting due to 
their effectiveness, but these medications have numerous side effects that could cause 
morbidity or even mortality (Casati & Putzu, 2004).  The obese population has multiple 
physiologic elements that increase their risk for opioid-induced respiratory depression. 
In addition to the potential adverse pharmacodynamic effects of opioid consumption, the 
physiological and pathophysiological alterations associated with obesity pose an 
increased risk for developing respiratory depression in the postoperative period in the 
presence of opioid administration (Nagelhout, 2014b).  The changes of obesity coupled 
with the adverse side effects of opioids could lead to respiratory or cardiac arrest during 
the postoperative period. 
Clinical Question 
Obesity is prevalent in Mississippi, and many of these patients subsequently are 
diagnosed with cholecystitis/cholelitiasis, which requires surgical removal of the 
gallbladder.  A clinical question was developed to determine if intravenous (IV) 
acetaminophen reduces the amount of opioid administration for postoperative pain in the 
post anesthesia care unit (PACU).  A decrease in opioid administration for postoperative 
pain in the PACU could improve patient safety, patient satisfaction, and cost-
effectiveness.  The population of interest was patients undergoing a routine procedure, 
laparoscopic cholecystectomy, which was chosen because the convenience sample 
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reflects the demographics of the population in Mississippi exhibiting obesity and 
cholecystitis requiring surgical intervention.  Oral and rectal acetaminophen has been 
used for several years and has been proven safe and effective.  The IV formulation of 
acetaminophen, Ofirmev® (acetaminophen) was approved for administration in the 
United States of America (U.S.) in 2010 and was utilized at the approved clinical site for 
postoperative pain relief until a drastic price increase.  Therefore, the following clinical 
question was established: Does IV acetaminophen reduce opioid use for postoperative 
pain in obese patients undergoing laparoscopic cholecystectomy? 
Problem Statement 
Postoperative pain has the potential to produce several undesirable problems; 
therefore, opioid drugs are frequently administered for moderate to severe pain.   
Opioid drugs reduce pain by depressing the central nervous system (CNS) unfortunately, 
“analgesia and respiratory depression are mediated by the same receptor” (Nagelhout, 
2014a, p. 149).  Opioid drug properties are potentiated by certain medical conditions 
including obesity, obstructive sleep apnea (OSA), and abdominal distention (Macintyre, 
Loadsman, & Scott, 2011).  The effects of opioids are further exacerbated, as well as the 
risk of apnea and hypoxemia because obese patients have (a) decreased lung compliance, 
(b) increased ventilation/perfusion (V/Q) mismatch, (c) diminished functional residual 
capacity (FRC), and (d) increased oxygen consumption (Argalious, 2009). 
Purpose of the Project 
The purpose of this capstone project is to produce a practice change in order to 
reduce the amount of opioids administered for postoperative pain to obese patients after 
undergoing a laparoscopic cholecystectomy and, therefore, reducing the opioid-related 
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adverse drug events (ORADE) in this population.  This study determined if obese patients 
undergoing laparoscopic cholecystectomy receiving IV acetaminophen require less 
opioid narcotics for postoperative pain management as compared to patients who did not 
receive IV acetaminophen.  Variables, including body mass index (BMI), gender, age, 
ethnicity, smoking status, American Society of Anesthesiologist (ASA) classification, 
total anesthesia time, time from IV acetaminophen to surgery start, total PACU time, total 
length of stay (LOS), amount of Dilaudid® (hydromorphone) given in the PACU, 
amount of hydromorphone given for the total LOS, adverse events experienced in and 
after the PACU, and discharge status.  Findings of this capstone project were 
disseminated to key stakeholders in a white paper proposal.  A white paper proposal is 
used to advocate a solution to a particular problem (The Writing Lab, The OWL at 
Purdue, & Purdue University, 2010).  This white paper proposal is intended to show the 
benefits of administering IV acetaminophen to obese patients undergoing a laparoscopic 
cholecystectomy to decrease opioid consumption for postoperative pain, and therefore, 
minimize ORADEs. 
Background and Significance 
Postoperative pain has the potential to produce several undesirable complications; 
therefore, opioid drugs are frequently administered for moderate to severe pain.  
Unfortunately, opioid administration may have detrimental outcomes, while relieving 
postoperative pain.  The two most serious ORADEs include unintended advancing 
sedation and respiratory depression. (Jarzyna, et al., 2011).  According to Overdyk, 
DeVita, and Pasero (2012), half of the patients that experience adverse respiratory events 
after surgery are those receiving opioids.  Patients who are at an increased risk of over-
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sedation and respiratory depression include (a) obese individuals, (b) patients with OSA, 
and (c) patients of advanced age (The Joint Commission, 2012). 
Obesity 
Obesity is a common occurrence in the U.S.  According to the Centers for Disease 
Control and Prevention (CDC), the latest adult obesity rate for the U.S. and Mississippi is 
35.7% and 34.6%, respectfully (CDC, 2014a; CDC, 2014b).  An obese patient requiring 
surgery presents multiple challenges for the anesthetist managing the airway, 
hemodynamic parameters, and drug therapy during the perioperative and postoperative 
period.   
Over the past 3 decades, the prevalence of morbid obesity has tripled (Ingrande, 
Brodsky, & Lemmens, 2009).  “Over the past decade, the prevalence of obesity in the 
world has dramatically increased across all age groups, especially in developed 
countries” (Xie, Waters, & Schirra, 2012, p. 1).  The obesity problem is rampant 
throughout the U.S., with 35.7% of Americans classified as obese (CDC, 2014a). In 
2011, 9 states have obesity rates above 30% (Lowry, 2012).  It has been forcasted that by 
2030, 2.16 billion adults will be overweight and 1.2 billion or over 44% will be obese 
worldwide (Levi, Segal, St. Laurent, Lang, & Rayburn, 2012; Popkin, Adair, & Ng, 
2012).  
The obesity rates have been increasing for some time, especially in Mississippi.  
Mississippi topped the obesity charts for 8 years consecutively, from 2004 to 2011.  In 
2012, Mississippi came in a close second to Louisiana; and in 2013, Mississippi was tied 
with West Virginia for first place at a rate of 35.1% (Trust for America’s Health & 
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Robert Wood Johnson Foundation, 2014).  If Mississippians continue on the current path, 
obesity rates are projected to rise to 66.7% by 2030 (Levi et al., 2012). 
 
Figure 1.  Mississippi and U.S. obesity rates over time. Information gathered from United 
Health Foundation, American Public Health Association (APHA), Partnership for 
Prevention, 2014; Trust for America’s Health, Robert Wood Johnson Foundation, 2015 
Obesity has been associated with increasing the risks of many preventable 
diseases and health issues, including: (a) type 2 diabetes (DM), (b) hypertension (HTN), 
(c) certain types of cancer, (d) OSA, (e) coronary artery disease (CAD), (f) stroke, (g) 
arthritis, (h) dyslipidemia, (i) metabolic syndrome, (j) osteoarthritis (OA), and (k) 
Alzheimer’s disease (Hindle & Mills, 2012; Eddey, 2012; Xie et al., 2012; Yaskin, 
Tones, & Goldfarb, 2009).  Obesity can also cause an individual to suffer from: (a) 
chronic pain, (b) inflammation, (c) gallstones, and (d) reduced fertility in women 
(Crawford, 2010; Kanasaki & Koya, 2010; Wikstrand, Torgerson, & Bostrom, 2010). 
Obesity is often times correlated to OSA, which decreases the oxygen carried in 
the blood (Hall, 2011; Kanasaki & Koya, 2010).  An increase in abdominal fat 
corresponds to an increase in instances of OSA due to the “upper airway mechanical 
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loads and/or decreasing compensatory neuromuscular responses” (Schwatz et al., 2008, p. 
188).  OSA also increases the risk of developing DM, CAD, and HTN (Kanasaki & 
Koya, 2010). 
Obesity is related to a decrease expansion of the intrathoracic cavity and 
accompanying decrease in alveolar ventilation, and FRC (Macintyre et al., 2011).  
General anesthesia (GA) further acerbates these deficits, and consequently alters gas 
exchange more drastically in obese patients.  The consequences of GA continue into the 
postoperative period; therefore, obese patients are at an increased risk of pulmonary 
complications during this time (Hans, Lauwick, Kaba, Brichant, & Joris, 2009).   
Because of the increased adipose tissue in obese patients, the volume of distribution is 
increased for all lipophilic pharmacodynamics agents (Nagelhout, 2014b). 
Laparoscopic Cholecystectomy 
A cholecystectomy is the removal of the gallbladder, and can either be performed 
as an open or a laparoscopic procedure.  The precipitating factor for requiring this 
procedure is either symptomatic gallstones or acute cholecystitis (Curet, Fanning, 
Brodsky, & Carvalho, 2009).  Cholecystitis is “inflammation of the gallbladder 
epithelium, often resulting from low-grade chronic infection” (Hall, 2011, p. 786).  
Gallstones are formed from: “(a) too much absorption of water from bile, (b) too much 
absorption of bile acids from bile, (c) too much cholesterol in bile, and/or (d) 
inflammation of epithelium” (Hall, 2011, p. 786). 
The first laparoscopic cholecystectomy was performed in 1985 by a German 
surgeon 103 years after the first cholecystectomy in 1882.  Since 1985, the laparoscopic 
approach has become the gold standard (Reynolds, 2001), the quantity of 
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cholecystectomy procedures performed in the U.S. has increased from around 500,000 to 
700,000 per year (Collins & McDowell, 2014).   
The laparoscopic approach to the cholecystectomy is preferred because it is 
minimally invasive and allows for a quicker recovery than an open approach.  
“Laparoscopic cholecystectomy may be contraindicated for patients with uncorrectable 
coagulopathy, severe chronic obstructive pulmonary disease (COPD), or severe cardiac 
disease (unable to tolerate increased intraabdominal pressure)” (Curet et al., 2009, p. 
575).  An increased risk of having to convert to an open procedure exists if the patient has 
had an open abdominal procedure in the past, or if the patient has acute cholecystitis 
(Curet et al., 2009). 
The liver secretes bile, which helps emulsify fat particles into ones that the body 
can absorb and use and assists in absorbing digested fat byproducts through the intestinal 
mucosa.  Bile also assists in removing waste products from the blood and excreting them 
by way of the intestinal tract.  After bile is secreted from the liver, it travels in the bile 
canaliculi into the terminal bile ducts until it reaches the hepatic duct and the common 
bile duct.  From here, bile either enters the duodenum or the cystic duct and into the 
gallbladder.  The gallbladder serves as a storage center for bile, holding 30 to 60 
milliliters, until it is needed in the duodenum (Hall, 2011). 
Postoperative Pain 
“Pain is a subjective feeling, and the perception of pain (pain threshold) can be 
influenced by affective (emotional), behavior, cognitive (beliefs and attitudes), sensory 
(perceptual), and physiologic factors” (Story, 2012, p. 428).  The two major 
classifications of pain include fast pain and slow pain.  Fast pain is perceived within 0.1 
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seconds after the incident, and slow pain is perceived after 1 second and increases in 
intensity.  Pain experienced from surgery includes both fast pain (surgical incision) and 
slow pain (tissue destruction).  Pain is elicited from mechanical, thermal, and/or chemical 
stimuli.  Unlike other sensory receptors in the body, pain receptors do not become 
sensitized.  As the pain persists, the pain receptors escalate in sensitivity, called 
hyperalgesia (Hall, 2011). 
Postoperative pain can be detrimental to the recovery of the patient, no matter 
what the surgical procedure is.  A few consequences of postoperative pain include HTN, 
tachycardia, and increased myocardial workload (Fowler & Spiess, 2013).  “Insufficient 
pain control in the postoperative period favors rapid and shallow breathing” (Hans et al., 
2009, p. 172).  “Negative clinical outcomes resulting from ineffective postoperative pain 
management include deep vein thrombosis (DVT), pulmonary embolism (PE), coronary 
ischemia, myocardial infarction (MI), pneumonia (PNA), poor wound healing, insomnia, 
and demoralization” (Apfelbaum, Chen, Mehta, & Gan, 2003, p. 534).  “Postoperative 
pain is associated with various complications and poor outcomes, including longer times 
to ambulation, longer hospital lengths of stay, higher rates of medical complications (e.g., 
venous thromboembolic disease from reduced activity), and decreased patient 
satisfaction” (Viscusi, Singla, Gonzalez, Saad, & Stepanian, 2012, p. 1). 
Intravenous Acetaminophen 
A possible solution to the management of postoperative pain relief without 
respiratory depression in obese patients in the PACU includes the addition of IV 
acetaminophen to opioid administration.  Acetaminophen has been used for over 100 
years in the oral and rectal forms to treat fever, headache, and dysmenorrhea (Ramasubbu 
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& Gupta, 2013).  An IV preparation of acetaminophen, Perfalgan (paracetamol), was 
approved in 2001 for use outside the U.S., in nearly 80 countries (Buck, 2011).  In 
November 2010, the Food and Drug Administration (FDA) approved Ofirmev® 
(acetaminophen) “for (a) the management of mild to moderate pain, (b) the management 
of moderate to severe pain with adjunctive opioid analgesics, and (c) the reduction of 
fever” in patients greater than 2 years old (Department of Health and Human Services 
[DHHS], Public Health Service, Food and Drug Administration, Center for Drug 
Evaluation and Research, Office of Surveillance and Epidemiology, 2012, p. 2).  
Acetaminophen’s mechanism of action remains uncertain despite being a 
relatively safe, effective medication.  Some of the theories regarding the mechanism of 
action include (a) inhibition of cyclooxygenase activity and prostaglandin creation, (b) 
interaction or activation of endogenous pain pathways, and (c) increase in cannabinoid-
like activity (Golembiewski, 2011; Ramasubbu & Gupta, 2013).  Acetaminophen has 
insignificant effects on the circulatory, pulmonary, and coagulation systems when staying 
within the recommended dosages, which is less than 4 grams per day, regardless of the 
route of administration (Ramasubbu & Gupta, 2013; Mallinckrodt Pharmaceuticals, 
2014).  In cases where the patient consumed more than the recommended daily 
allowance, acute liver failure and death occurred in some cases (Mallinckrodt 
Pharmaceuticals, 2014). 
Acetaminophen can be administered through three different routes.  The oral form 
of acetaminophen has good bioavailability, 30-45 minute onset of analgesia, and the 
maximum analgesia is within 60 minutes of consumption.  The rectal form of 
acetaminophen has unpredictable bioavailability, the onset of analgesia is 2 hours, and 
10 
 
the maximum analgesia is achieved in 2-5 hours after administration.  The IV form of 
acetaminophen has excellent bioavailability, the onset of analgesia is less than 10 
minutes, and the maximum analgesia is achieved in 15 minutes (Golembiewski, 2011). 
Table 1 
Acetaminophen route comparison 
    
Route of 
Administration 
Bioavailability Onset of Analgesia Maximum 
Analgesia 
    
    
Intravenous 100% 10 minutes 15 minutes 
Oral 60 – 70% 30-45 minutes 60 minutes 
Rectal 30-40% 2 hours 2-5 hours 
IV acetaminophen can be administered as a single dose or repeated dose as a 15-
minute infusion.  IV acetaminophen is contraindicated in patients with (a) a known 
allergy to acetaminophen, (b) severe active liver disease, or (c) severe hepatic 
impairment.  Administer IV acetaminophen with caution in patients with (a) chronic 
malnutrition, (b) chronic alcohol consumption, (c) profound hypovolemia, or (d) a 
creatinine clearance less than or equal to 30 mL/min.  The most common side effects of 
IV acetaminophen administration in adults include (a) nausea, (b) vomiting, (c) insomnia, 
and (d) headache (Mallinckrodt Pharmaceuticals, 2014). 
In January 2011, the FDA released a safety announcement requesting drug 
manufacturers to limit the quantity of acetaminophen used in prescription medications to 
325 milligrams (mg) and add a boxed warning.  This press release is in response to the 
increased consumption of acetaminophen from various medications, unbeknownst to the 
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consumer, which may result in liver failure or accidental overdose (FDA, 2014).  
“Acetaminophen is an active ingredient in hundreds of over-the-counter (OTC) and 
prescription medications,” including those that relieve symptoms for cough, colds, flu, 
allergies, sleeplessness, pain, and fever (FDA, 2015).  However, acetaminophen is still a 
safe drug if the maximum daily allowance is not exceeded. 
Multimodal Pain Management 
Most anesthetists utilize the concept of multimodal pain management during the 
intraoperative period.  According to Young and Buvanendran (2012), “multimodal 
analgesia captures the effectiveness of individual agents in optimal dosages that 
maximize efficacy and attempts to minimize side effects from one analgesic” (p. 91). 
Generally, the use of multiple analgesic medications is associated with fewer adverse 
effects, enhanced pain relief, improved patient outcomes, and greater patient satisfaction 
(Williams & Buvanendran, 2009).  A multimodal analgesic approach is advantageous for 
all surgery patients, especially for the obese patients due to the reduction of opioid 
administration and associated side effects (Hans et al., 2009). 
IV acetaminophen is a valuable component in multimodal pain analgesia for most 
patients.  IV acetaminophen “produces its analgesic effect by inhibiting central 
prostaglandin synthesis with minimal inhibition of peripheral prostaglandin synthesis” 
(Williams & Buvanendran, 2009, p. 118).  IV acetaminophen is relatively safe and does 
not produce the unwanted side effects of opioids (respiratory depression, decreased 
gastric motility, and increased risk of substance abuse) or nonsteroidal anti-inflammatory 
drugs (NSAIDs) (impair platelet function or impaired renal function) (Viscusi et al., 
2012). 
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Opioids 
Opium, “the brownish residue observed after the poppy’s juice is desiccated,” is 
the basis of over 20 opiate alkaloids (Ogura & Egan, 2013, p. 253).  “Opioid is a term 
used to refer to a group of drugs, both naturally occurring and synthetically produced, 
that possess opium- or morphine-like properties” (Nagelhout, 2014a, p. 145).   
The first IV opioid was administered in 1853, after the invention of the syringe and 
needle.  However, Greek literature refers to opium being used as early as 300 BC 
(Nagelhout, 2014a). 
According to Ogura and Ergan (2013), the term opioid “is used to designate all 
substances, both natural and synthetic, that bind to opioid receptors (including 
antagonists)” (p. 253).  There are three major opioid receptors in the human body, 
including mu (μ), Kappa (κ), and delta (δ) (Scott & Ballantyne, 2013).  Stimulation of the 
μ opioid receptor produces the following effects: (a) supraspinal and spinal analgesia; (b) 
bradycardia; (c) respiratory depression; (d) CNS effects including euphoria, sedation, 
mild hypothermia, prolactin release, indifference to environmental stimulus, and 
catalepsy; (e) miosis, or contraction of the pupils; (f) inhibition of peristalsis, nausea, and 
vomiting; (g) urinary retention; (h) prutitus; and (i) physical dependence.  Stimulation of 
the κ opioid receptor produces the following results: (a) supraspinal and spinal analgesia; 
(b) possible respiratory depression; (c) CNS effects including sedation, delirium, and 
dysphoria; (d) miosis; (e) diuresis due to inhibition of vasopressin release; (f) low 
physical abuse probability; and (g) antishivering.  Activation of the δ opioid receptor 
yields the following outcomes: (a) supraspinal and spinal analgesia; (b) respiratory 
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depression; (c) urinary retention; (d) prutitus; and (e) physical dependence (Nagelhout, 
2014a). 
Table 2 
Opioid Receptors and their effects 
  
Opioid Receptor Effects 
  
Mu (μ) Supraspinal and spinal analgesia; bradycardia; respiratory 
depression; CNS effects including euphoria, sedation, mild 
hypothermia, prolactin release, indifference to 
environmental stimulus, and catalepsy; miosis, or 
contraction of the pupils; inhibition of peristalsis, nausea, 
and vomiting; urinary retention; prutitus; and physical 
dependence 
  
Delta (δ) Supraspinal and spinal analgesia; respiratory depression; 
urinary retention; prutitus; and physical dependence 
  
Kappa (κ) Supraspinal and spinal analgesia; possible respiratory 
depression; CNS effects including sedation, delirium, and 
dysphoria; miosis; diuresis due to inhibition of vasopressin 
release; low physical abuse probability; and antishivering.   
  
The effects of opioid medications are produced when the opioid agonist binds to 
the mu, kappa, or delta opioid receptor, “which couple to G proteins and inhibit adenyl 
cyclase” (p. 299).  This binding results in the inhibition of voltage-gated calcium 
channels and the opening of potassium channels, leading to hyperpolarization or 
inhibition of the transmission of the sensation of pain (Fuller, 2012).  Three main 
classifications of opioids exist: (a) phenanthrene alkaloids, (b) piperidine derivatives or 
phenylpiperidines, and (c) diphenylheptanes.  Phenanthrene alkaloids consist of natural 
occurring (morphine, codeine), semisynthetic (hydrocodone, hydromorphone, 
oxycodone, and oxymorphone), and synthetic (butorphanol).  Piperidine derivative 
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classification includes phenylpiperidines (Demerol) and 4-Anilidopiperidines (fentanyl, 
sufentanil, alfentanil, and remifentanil) (Nagelhout, 2014a). 
Opioids reduce ventilation, mainly in the form of respiratory rate, as well as 
increase the partial pressure of carbon dioxide (PaCO2).  An increase in PaCO2 blunts the 
response to carbon dioxide (CO2), which enables apneic episodes to become more likely 
(Butterworth, Mackey, & Wasnick, 2013).  Opioid drug properties are potentiated by 
certain medical conditions including obesity, OSA, and abdominal distention (Macintyre 
et al., 2011).  Because obese patients have (a) decreased lung compliance, (b) increased 
V/Q mismatch, (c) reduced FRC, and (d) increased oxygen consumption; the effects of 
opioids are further exacerbated, as well as the risk of apnea and hypoxemia (Argalious, 
2009). 
The use of opioids in obese patients for the management of postoperative pain in 
the PACU could produce significant pulmonary complications including respiratory 
depression that could lead to death.  Obese patients are already at a greater risk of 
pulmonary complications due to the increase in intrathoracic pressure that inhibits the 
lungs from fully expanding, with subsequent decrease in FRC and alveolar ventilation.  
The addition of IV acetaminophen to opioid administration for moderate to severe pain 
management in obese patients may reduce the risk of respiratory depression and death. 
Opioid-induced respiratory depression is classified as a sentinel event, which is an 
unanticipated occurrence that may result in severe injury or death.  The incidence and 
significance of opioid-induced respiratory depression are not well documented in the 
literature.  One source approximated the incidence to be 0.5% with a range of 0.2 to 2% 
(Dahan, Niesters, Olofsen, Smith, & Overdyk, 2013).  The Anesthesia Patient Safety 
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Foundation (APSF) (2011) noted “clinically significant, drug-induced respiratory 
depression in the postoperative period remains a serious patient safety risk that continues 
to be associated with significant morbidity and mortality” (p. 1). 
Conclusion 
Uncontrolled postoperative pain after any surgical procedure can have devastating 
effects for the healing process.  Opioids are predominately administered for analgesia 
during the perioperative period.  However, side effects of opioids could be fatal, 
particularly for the obese patient.  Obese patients are at a higher risk for adverse events 
during the perioperative period due to changes in body habitus.  Because changes 
associated with obesity combined with unfavorable side effects of opioids is a dangerous 
mixture, the addition of IV acetaminophen during the preoperative period is beneficial in 
decreasing opioid administration for postoperative pain in the obese surgical patient. 
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CHAPTER II 
REVIEW OF LITERATURE 
This paper contains a synthesis of literature regarding the following topics: (a) IV 
acetaminophen for the reduction of postoperative pain, (b) multimodal therapy, and (c) 
ORADEs.  The following databases were utilized for this review of literature: 
EBSCOhost, MEDLINE, PubMed, ScienceDirect, and Google Scholar.  The key words 
used in the search included: (a) Ofirmev, (b) Paracetamol, (c) IV acetaminophen, (c) 
obese, (d) obesity, (e) opioids, (f) laparoscopic cholecystectomy, (g) opioids and 
respiratory depression, and (h) opioid-related adverse drug events.  
Intravenous Acetaminophen for the Reduction of Postoperative Pain 
Memis, Inal, Kavalci, Sezer, and Sut (2010) preformed a quantitative single 
randomized controlled trial that evaluated the analgesic efficacy, adverse outcomes, and 
time to extubation in 40 adult intensive care unit (ICU) patients after complex abdominal 
or pelvic surgery.  The participants received IV paracetamol (acetaminophen) as an 
adjuvant to IV meperidine or only IV meperidine for postoperative pain.  This study 
found that pain scores, time to extubation, and the incidence of sedation and 
postoperative nausea and vomiting (PONV) were considerably lower in the group that 
received both IV acetaminophen and meperidine. 
Wininger et al. (2010) conducted a double blind, placebo-controlled, parallel-
group study at 17 different sites in the U.S., with 244 adult participants.   
This study assessed the analgesic effectiveness and safety of repetitive doses of IV 
acetaminophen over a 24-hour period when compared to a placebo after abdominal 
laparoscopic surgery.  The four groups in the study included: (a) IV acetaminophen 1000 
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mg every 6 hours, (b) IV acetaminophen 650 mg every 4 hours, (c) IV placebo every 6 
hours, and (d) IV placebo every 4 hours for 24 hours postoperatively.  Both treatments of 
IV acetaminophen were associated with analgesic efficacy in these patients. 
A prospective randomized, double-blind clinical trial, that included 142 total 
participants, was led by Konstantatos, Smith, and Angliss (2012).  The aim of this study 
was to assess whether IV acetaminophen will reduce postoperative pain and time to 
discharge from the PACU and the hospital.  The three groups investigated included (a) 
the pre and postoperative placebo, (b) the IV intraoperative and postoperative oral 
acetaminophen, and (c) the pre and postoperative oral acetaminophen.  Konstantatos et al. 
(2012) found that the mean pain scores and the time to discharge over 24 hours during the 
postoperative period was not significantly different between the 3 groups.  The 
researchers did indicate that the anesthetists could use fentanyl and morphine as needed 
for pain during the intraoperative period, and the surgeons were allowed to use local 
anesthetic as desired.  Another limitation was that the population was predominately 
young, healthy males. 
Atef and Fawaz (2008) conducted a randomized, double blind, prospective, 
placebo-controlled study with 76 adult subjects aged 16-40 years old, scheduled for 
elective bipolar diathermy tonsillectomy to evaluate the efficacy of IV paracetamol 
(acetaminophen) for pain control.  The experimental (n=38) group received 1-gram 
acetaminophen and the control (n=38) group received normal saline all participants 
received the designated treatment every 6 hours.  Rescue analgesia during the first 24 
hours postoperatively was available to all patients.  Rescue analgesia was required in 
100% of patients in the placebo group and 29% of patients in the acetaminophen group.  
18 
 
Therefore, the authors concluded that IV acetaminophen did provide effective pain relief 
and provided a significant opioid sparing effect in their target population. 
Anand et al. (2013) preformed a parallel, randomized, double blind, comparative 
study that included 180 patients to establish if IV acetaminophen or IV ketorolac 
delivered better analgesia after parathyroidectomy.  One group (n=90) was administered 
1 gram IV acetaminophen at the beginning of the surgical procedure, and the other group 
(n=90) received 30 mg IV ketorolac at the close of the fascia.  The researchers concluded 
that the ketorolac group had lower pain scores than the acetaminophen group (3.9±1.9 vs. 
4.8±2.4 at 45min, p=0.009; 3.4±1.7 vs. 4.5±2.1 at 60min, p=0.04; and 3.2±2.1 vs. 4.4±2.1 
at 75min, p=0.03). 
A retrospective analysis was directed by Smith and Hoefling (2014) to determine 
if IV acetaminophen could decrease visual analog scale (VAS), opioid exposure, and 
ORADEs in spinal surgery patients.  A total of 68 electronic medical records (EMRs) 
were assessed and reviewed.  The experimental group (n=34) received 1 gram IV 
acetaminophen either preoperatively or postoperatively, and the control group (n=34) did 
not receive IV acetaminophen.  The results of this study indicated that the acetaminophen 
group used less opioids (11.3 mg morphine equivalent [ME]) than the control group (20.6 
mg ME) (P=0.015).  The only administration of naloxone was in one control group 
patient.  Although this analysis indicated that IV acetaminophen reduced opioid 
consumption, VAS scores or the administration of antiemetic and laxatives did not differ 
between the two groups. 
A systemic review, directed by Tzortzopoulou et al. (2011) assessed the efficacy 
and safety of IV propacetamol (acetaminophen) for the treatment of postoperative pain in 
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adults and children.  This review examined 36 randomized, double-blind, placebo- or 
active-controlled single dose clinical trials, which included a total of 3,896 participates.  
The results of this systematic review showed that 37% of the participants that received IV 
acetaminophen had a decrease in pain of 50% over 4 hours, compared to 16% that 
received the placebo.  The study also indicated that the IV acetaminophen group required 
30% less opioids over 4 hours than the placebo group.  However, no significant 
difference in the number of ORADEs between the IV acetaminophen and the placebo 
groups was noted. 
Singla et al. (2014) reviewed two double-blind, parallel-group, multicenter, 
randomized, placebo-controlled clinical trials to determine the efficacy and safety of IV 
acetaminophen for postoperative pain after hip arthroplasty.  Both clinical trials were 
terminated early due to particulate matter and altered pH in the placebo vials.  The 2 
studies yielded 130 participants, all with similar demographics.  Mean pain intensity 
difference (PID) of IV acetaminophen group was consistently higher than placebo with 
significant (P<0.5) differences from T0.25 to T5 in the first study and T0.5 to T4 in the 
second study, which indicated that IV acetaminophen relieved postoperative pain 
compared to placebo.  VAS scores were consistently superior in IV acetaminophen than 
placebo.  IV acetaminophen decreased opioid consumption for up to 6 hours in the first 
study and up to 4 hours in the second study.  The mean time for rescue analgesia for IV 
acetaminophen was 4.72 compared to placebo 1.4 in the first study, and >4 and 1.25, 
respectfully in the second study.  The reviewers concluded that IV acetaminophen 
improved postoperative analgesia with a rapid onset, and decreased opioid consumption 
more than 50% when compared to placebo. 
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Multimodal Therapy 
A qualitative systematic review that was led by Ong, Seymour, Lirk, and Merry 
(2010) evaluated the efficacy of combining acetaminophen and a NSAID versus 
administration of each medication alone in varied acute pain models.  This systematic 
review included 21 studies, with a total of 1909 patients.  This review indicated that 
combining acetaminophen and a NSAID provides additional analgesic efficacy when 
compared with either drug alone. 
Macario and Royal (2010) conducted a systematic review to evaluate the 
analgesic effects of IV acetaminophen for acute pain in adults.  The review included 22 
studies from 9 countries, and a total of 1,464 patients were examined.  The researchers 
reported that IV acetaminophen had similar analgesic effects as an active comparator (IV 
parecoxib [n=3], IV metamizol [n=4], and oral ibuprofen [n=1]) in 7 out of 8 studies.  
Patients who received IV acetaminophen versus a placebo had decreased postoperative 
pain in 12 of 14 studies. 
A retrospective chart review was done by Lewis, Gunta, Mitchell, and Bobay 
(2012) to evaluate the outcomes of multimodal analgesia in total knee arthroplasty 
(TKA).  The chart review consisted of a control group of 45 patients from 2009 and a 
multimodal group of 66 patients from 2010.  A multimodal protocol for TKA was 
developed that consisted of several oral and IV analgesics, along with a femoral 
continuous peripheral nerve block (PNB).  Although this chart analysis had several 
limitations, the researchers concluded that the multimodal had less pain scores and 
decreased incidence of PONV in the postoperative area.  The length of stay (LOS) in the 
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multimodal group was reduced by 0.5 days compared to the control group (3.22, 2.75, 
p<.01). 
Xiromeritis, Kalogiannidis, Papadopoulos, Prapas, and Prapas (2011) conducted a 
prospective, randomized trial to evaluate postoperative pain when multimodal therapy is 
used in females undergoing uterine fibroid surgery.  A total of 92 participants took part in 
the study and were allocated into either the multimodal group (n=47) or the control group 
(n=45) using sealed envelopes.  Pain scores were documented at 2 and 8 hours 
postoperatively.  This study indicated that the mean pain scores were significantly lower 
in the multimodal group when compared to the control group (2 hours postoperatively: 
4.7 ± 0.7 vs 7.1 ± 0.9, P < 0.0001; 8 h postoperatively: 2±0.6 vs 4.5±0.8, P<0.0001).   
The multimodal group also had a reduced hospital LOS compared to the control group, 
which is thought to indicate a faster recovery time (11 ± 5 vs 26.8 ± 5.8 h, P < 0.0001). 
Opioid-Related Adverse Drug Events 
A retrospective cohort study was completed by Minkowitz, Gruschkus, Shah, and 
Raiu (2014), which included 6,285 patients, 18 years and older, who had inpatient 
surgical procedures within 11 hospitals in the Houston metropolitan area in the year 
2010.  ORADEs and the associated risk factors were examined in this study.   
The researchers found that 99.8% (n=6,274) of the participants were administered opioids 
in the postoperative period, and of those, 11.0% (n=689) experienced ORADEs.   
The most frequently occurring ORADEs involve the gastrointestinal (GI) system (6.3%, 
n=396), whereas those involving the respiratory system was 2.9% (n=182) of patients.  
The researchers identified multiple risk factors that were linked to ORADEs, and 
included: (a) advanced age, (b) male gender, (c) prior opioid use, (d) COPD, (e) cardiac 
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dysrhythmias, (f) regional enteritis, (g) diverticulitis, and (h) ulcerative colitis.  Higher 
hospital costs correlated with increasing number of risk factors for ORADEs. 
Oderda et al. (2007) investigated the impact of ORADEs on hospital LOS in a 
retrospective matched cohort study.  The ORADE group (n=741) were identified by a 
computer surveillance program, then each ORADE was matched with 15 control cases, 
making the control group (n=10,116).  The researchers concluded that the ORADE group 
when compared with the control group had an increase in hospital costs (7.4%, p<0.001), 
and an increase in mean LOS (10.3%, P<0.001).  The higher the dose of opioids 
corresponded to the rate of ORADEs. 
Pizzi et al. (2012) undertook a retrospective chart review to determine if ORADEs 
had an impact on postoperative hospital LOS.  A stratified, random sample of patients 
(n=402), 18 years or older who underwent spine, hip, knee, or shoulder surgery during 
2007, were selected, and data gathered from each patient’s EMR.  This study found that 
at least 1 ORADE occurred in 54.2%, 2 ORADEs occurred in 18.4%, and 3 or more 
ORADEs occurred in 7.2% of the participants.  However, the number of ORADE showed 
no correlation to the type of surgical procedure.  The ORADEs that caused a significant 
increase in LOS included constipation, emesis, and confusion. 
Eckstrand et al. (2009) completed a retrospective, cross-sectional study to 
examine opioid-related over-sedation and respiratory depression after naloxone 
administration (n=419) during the perioperative period.  A computerized surveillance 
system was used for identification of adverse drug events (ADEs), including naloxone 
administration at Duke University.  Out of 419 cases of perioperative naloxone 
administration that were identified, 101 doses were given postoperatively, and 69 were 
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confirmed as ADEs after chart review.  The researchers found a rate of 1.89 ADEs/1000 
surgical encounters across both the inpatient and ambulatory settings within Duke 
University during the postoperative period.  
Needs Assessment 
The addition of IV acetaminophen for the management of postoperative pain in 
obese patients undergoing laparoscopic cholecystectomy is not the standard of care, but 
should it be?  Postoperative pain in any population may produce adverse consequences, 
and could be exaggerated in the obese population.  The gold standard for the treatment of 
postoperative pain is opioids, but these medications may produce harmful side effects. 
Obesity has become a national epidemic, and Mississippi, unfortunately, has been 
leading the way for several years (Trust for America’s Health & Robert Wood Johnson 
Foundation, 2014).  “In the obese patient, the goal of postoperative pain management is 
provision of comfort, early mobilization and improved respiratory function without 
causing inadequate sedation and respiratory compromise” (Schug & Raymann, 2011, p. 
73).  The maintenance dosages of opioids for the management of postoperative pain in 
the PACU “should be cautiously reduced because of the higher sensitivity of the obese 
patient to their depressant effects” (Casati & Putzu, 2004, p. 134).  Another source adds 
that the serious complications of opioids can conceivably lead to respiratory depression 
and death (Overdyk et al., 2012). 
Effective management of postoperative pain is the goal of each anesthetist, 
especially for the obese patient.  If postoperative pain is adequately managed, not only 
does patient satisfaction increase, but also the risks of postoperative complications 
decrease.  Postoperative pain is typically treated with opioids, which may cause apnea 
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and other undesirable effects in the obese patient (Schug & Raymann, 2011).  The desired 
outcome for this capstone project is to access whether the administration of IV 
acetaminophen in obese patients undergoing laparoscopic cholecystectomy reduces the 
amount of opioids required for the management of postoperative pain. 
Decreasing the prevalence of postoperative pain and opioid consumption along 
with their adverse side effects will improve patient outcomes and satisfaction.  Because 
this project is a retrospective chart review, buy-in from the facility was accomplished 
since there are no added work or costs.  Risks of a retrospective chart review include 
collecting incomplete or inadequate documentation to complete all aspects of the project.  
The outcome analysis of this capstone revealed and answered the question if IV 
acetaminophen will decrease opioid use for postoperative pain in obese patients 
undergoing laparoscopic cholecystectomy, and results will contribute to a possible 
change in practice.  
Conceptual Framework 
The Theory of Goal Attainment is a middle-range theory.  A middle range theory 
is more focused when compared to grand theories, and the concepts of the middle range 
theory can form a testable hypothesis (Eldridge, 2014).  Imogene King introduced the 
Theory of Goal Attainment in the 1960s.  The essential concept of this theory is that the 
patient and nurse correspond with one another to develop goals and then act to attain the 
desired goals (Nursing theory, 2013). 
The basic assumptions of the theory include individuals are (a) social, (b) sentient, 
(c) rational, (d) reacting, (e) perceiving, (f) controlling, (g) purposeful, (h) action-
oriented, and (i) time-oriented beings.  Other basic assumptions of the theory that impact 
25 
 
the interaction process include: (a) views of the nurse (b) views of the patient (c) goals, 
wishes, and beliefs of the nurse goals, wishes, and beliefs of the patient.  In addition to 
these assumptions, persons are entitled to information regarding their health; and persons 
are also entitled to partake in decision-making that will impact their long-term care and 
wellbeing.  The Goal Attainment Theory also states that persons are entitled to accept or 
decline care and treatment; and the goals of nurses and patients may be different (King, 
1981).  The major concepts of the Theory of Goal Attainment include (a) personal, (b) 
interpersonal, and (c) social (Nursing theories, 2012). 
Application of the Theory of Goal Attainment to Capstone 
The Theory of Goal Attainment emphasizes a holistic approach and describes the 
nursing profession as a process that is collaborative in nature (Whetsell, Gonzalez, & 
Moreno-Fergusson, 2011).  A lack of sufficient pain control after surgery has the 
potential to cause quick and shallow respirations (Hans et al., 2009). The main agent used 
to control pain management in the PACU is opioids.  “Unintended advancing sedation 
and respiratory depression are two of the most serious opioid-related adverse events” 
(Jarzyna, et al., 2011, p. 118).  According to Overdyk et al. (2012), the administration of 
opioids in the postoperative period is said to be responsible for half of the adverse 
respiratory events during that period.  The APSF (2011) reported that adverse respiratory 
events caused by opioids in the PACU continue to be linked with substantial illness and 
death. 
Analysis of the Theory of Goal Attainment-Capstone Fit 
The Theory of Goal Attainment is based on the King Conceptual System.   
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This system indicates that the goals of the patient are met through the interaction between 
the nurse and the patient.  This interaction happens over time, comprises a transaction, 
and ultimately the goal is met (Whetsell et al., 2011).  The Theory of Goal Attainment 
includes awareness, communication, and collaboration between the patient and the nurse 
(Nursing Theories, 2012).  This communication between the nurse and patient is 
important in the early recognition and treatment of postoperative pain. 
Future Practice Implications for the Theory of Goal Attainment 
A middle-range theory integrates nursing practice and research into concepts that 
are fundamental to the discipline (Terry, 2012). The Theory of Goal Attainment is 
applicable for every setting in healthcare and always will be.  Nursing is based on goal-
setting and patient-centered care.  In health care, the affiliation of the patient and the 
nurse exists to assist that patient in accomplishing his or her objectives for their health 
(Nursing theory, 2013). 
Doctorate of Nursing Practice Essentials 
Doctorate of Nursing Practice (DNP) Essential I is scientific underpinnings for 
practice.  This essential allows for the development and assessment of clinical practice 
solutions based on theories from nursing and other disciplines (Chism, 2013a).  
Intravenous acetaminophen administration reduces the amount of opioids used in the 
postoperative period.  This evidence-based practice approach is created using many other 
disciplines including pathophysiology, pharmacology, anatomy, and physiology.  The use 
of IV acetaminophen to reduce postoperative pain is particularly imperative for obese 
surgical patients due to the pharmacodynamics and pharmacokinetics of opioid 
administration. 
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DNP Essential II is organizational and systems leadership for quality 
improvement and systems thinking (Chism, 2013a).  This capstone project is focused on 
the reduction of opioid administration for postoperative pain in obese patient who 
underwent laparoscopic cholecystectomy.  The administration of IV acetaminophen may 
improve postoperative pain without the negative side effects of multiple doses of opioids 
(Viscusi et al., 2012).  If this proves true, a practice change will likely be established to 
improve patient safety and satisfaction.   
DNP Essential III is clinical scholarship and analytical methods for evidence-
based practice (Tymkow, 2014).  Dreher (1999) stated, “clinical scholarship is about 
inquiry and implies a willingness to scrutinize our practice” (p. 26).  This capstone 
project assessed the methods currently used to prevent postoperative pain in obese 
patients. 
DNP Essential IV is information systems or technology and patient care 
technology for the improvement and transformation of healthcare.  According to Chism 
(2013a), Essential IV is imperative to the DNP graduate.  This essential allows for 
evaluation and implementation of quality improvement programs, data extraction from 
patients’ EMR, and knowledge of ethical and legal issues regarding the patient’s EMR 
(Chism, 2013a).  Performing a retrospective chart review, patient data was extracted from 
the patients’ EMR, de-identified, and protected to avoid ethical and legal issues.  Other 
electronic databases were utilized for the review of literature and other pertinent 
information dealing with laparoscopic cholecystectomy in the obese patient, 
postoperative pain in the obese patient, opioid administration in the obese patient, and IV 
acetaminophen for the reduction of postoperative pain. 
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DNP Essential V is healthcare policy for advocacy in healthcare.  Mund (2014) 
asserted, “the complexity of today’s healthcare environment and the increase in volume 
of scientific knowledge demand the involvement of nurses educated in the legislative 
process and prepared to influence policy on the local, state, and national levels” (p. 177).  
If the assumptions of this capstone project prove true, advocacy for a practice change will 
be required for the reduction in opioid administration for postoperative pain in the obese 
patient after a laparoscopic cholecystectomy, and the reduction of ORADEs in this 
population. 
DNP Essential VI is interdisciplinary collaboration.  Interdisciplinary 
collaboration is vital to any clinical setting in order to adequately care for the patient.  For 
the obese surgery patient, interdisciplinary collaboration between the anesthetist and the 
PACU nurse is vital for patient safety and includes informing the PACU nurse of adverse 
or unanticipated events during the perioperative period, how the patient responds to 
certain medications, and any problems that could possibly occur.  Interdisciplinary 
collaboration can be developed by respecting the knowledge and expertise of other team 
members, asking for input from other team members, and communicating “effectively by 
utilizing active listening, compassion, and empathy” (Chism, 2013c, p. 76). 
DNP Essentials VII is clinical prevention and population health for improving the 
nation’s health (Schadewald & Pfeiffer, 2014).  Clinical prevention is defined by the 
American Association of the Colleges of Nursing (AACN) (2006) as “health promotion 
and risk reduction/illness prevention for individuals and families” (p. 15).  The 
administration of excessive opioids produces harmful side effects, especially in the obese 
patient.  These adverse side effects could cause respiratory depression and detrimental 
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effects on the patient’s health and postoperative recovery (Nagelhout, 2014b).  This 
project evaluated the use of IV acetaminophen and opioid administration in the 
postoperative period, which could potentially improve the outcomes for this population. 
DNP Essentials VIII is advanced nursing practice (Chism, 2013a).  This essential 
emphasizes holistic assessment, implementation, and evaluation of health care 
interventions to enhance patient care and improve patient outcomes.  Effective 
communication among all members of the healthcare team, along with the patient is an 
essential key to achieving this goal (Chism, 2013a).  Communication throughout the 
perioperative period is crucial for any surgical procedure in order to provide the desired 
outcomes for that patient.  This communication should be continued during the 
postoperative period so that the patient receives optimal care.  Minimizing the use of 
opioids in PACU in a patient with a low tolerance to these medications, as evidenced by 
their reaction during induction of anesthesia, is vital to their recovery.  This information 
should always be communicated to the PACU nurse who will be caring for that patient.  
The use of IV acetaminophen will reduce postoperative pain and the quantity of opioids 
required to manage pain.  The reduction of opioid use for postoperative pain may 
improve patient outcomes and decrease the number of adverse events during the 
postoperative period. 
Leadership skills are essential for the advanced practice registered nurse (APRN), 
especially in initiating a change in clinical practice that will be effective and beneficial 
for patient safety and outcomes.  A few approaches for being an effective leader in order 
to improve adverse events for obese patients in the PACU, with regards to postoperative 
pain management, include giving a thorough perioperative report to the PACU nurse, 
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giving the PACU nurse a chance to ask questions, and giving positive feedback (Center 
for Creative Leadership, 2013).  Additional leadership skills in order to address this 
clinical practice issue include: (a) effective communication, (b) fearlessness, (c) being a 
role model, (d) knowledge and clinical competence, (e) compassion, (f) being 
trustworthy, and (g) empathy (Chism, 2013b). 
Evaluation Plan 
The desired outcome of this capstone project is to decrease the amount of opioid 
administration for postoperative pain, along with ORADEs in obese patients undergoing 
laparoscopic cholecystectomy with the use of IV acetaminophen.  This outcome was 
measured using a retrospective chart review of the amount of opioid administration 
during the postoperative period and the entire LOS for those patients who did and did not 
receive IV acetaminophen in the desired population.  This outcome was measured and 
evaluated in each group using the t-test.  “The t-test analyzes the size of the difference 
between the means of two groups while taking into account the sample size and the 
spread of the scores across the possible range of scores (i.e., the standard deviation)” 
(Brown, 2014, p. 179-180). 
Assumptions 
The assumption for this project is that there will be adequate documentation of 
medication administration and any adverse events that occurred during the perioperative 
period.  These assumptions are unlikely due to the advent of the EMR.  The medical 
facility where this study took place uses the EPIC EMR.  According to Menachemi and 
Collum (2011), the Health Information Technology for Economic and Clinical Health 
(HITECH) Act of 2009 gave U.S. medical facilities an initiative to enact and use the 
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EMR.  Potential advantages “include clinical outcomes (improved quality, reduced 
medical errors), organizational outcomes (financial and operational benefits), and societal 
outcomes (improved ability to conduct research, improved population health, and reduced 
costs)” (p. 47). 
Conclusion 
The majority of studies found that IV acetaminophen decreases postoperative 
pain, opioid consumption, and LOS.  IV acetaminophen, along with other NSAIDs 
should be considered in every surgical patients plan of care, specifically obese patients.  
This multimodal approach to analgesia is utilized to reduce the ORADEs while providing 
adequate pain relief.  Another vital aspect of analgesia is communication between the 
patient and PACU nurse.  According to theory of goal attainment, patient-nurse 
interaction is critical for providing exceptional care in the postoperative period. 
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CHAPTER III 
METHODOLOGY 
Using the PICO (population/intervention/comparison/outcome) question structure, 
the following research question was developed: ‘In obese patients undergoing 
laparoscopic cholecystectomy, does IV acetaminophen reduce opioid use for 
postoperative pain?’  A retrospective comparison quantitative approach was used to 
answer this research question.  A retrospective study was chosen because the proposed 
intervention and the proposed effect have occurred in the recent past (Grove, Burns, & 
Gray, 2013).  The researcher documented all patient information on the data collection 
form (DCF) so that subjects cannot be identified, directly or indirectly.  Confidentiality of 
patient information was maintained during the study.  
Setting 
This retrospective study was conducted at a large, level II regional trauma center 
in the southeast.  This facility houses 17 operating rooms, and delivers care to patients 
undergoing multiple types of procedures, including (a) general and thoracic surgery, (b) 
urology, (c) plastic surgery, (d) otolaryngology, (e) ophthalmology, (f) dentistry, (g) oral 
and maxillofacial surgery, (h) open heart procedures, (i) neurology, (j) minimally-
invasive laparoscopic procedures, and (k) vascular procedures. 
Population 
The population of interest for this retrospective chart review was obese adults 
with a BMI greater than 30 aged 18-65, who underwent an elective laparoscopic 
cholecystectomy.  Obesity is a common occurrence in the U.S., especially in Mississippi.  
Obesity is associated with many disease processes, including (a) OSA, (b) type 2 DM, (c) 
33 
 
dyslipidemia, (d) CAD, and (e) stroke (Hindle & Mills, 2012; Eddey, 2012; Xie et al., 
2012; Yaskin, Tones, & Goldfarb, 2009).  Obese patients are also at higher risk for 
adverse events associated with anesthesia, including (a) hypoxemia due to difficult bag 
mask ventilation, (b) difficult intubation due to excessive redundant tissue, and (c) 
increased pulmonary complication due to a decreased FRC. 
Sampling 
After IRB approval was received from the medical facility and USM (IRB 
#15012803), a sampling plan was implemented.  A sampling plan was used to augment 
representativeness, decrease bias, and reduce the sampling error (Grove, Burns, & Gray, 
2013).  The sampling frame was provided by the medical facility, and included a list of 
patient encounter numbers (PENs) for all patients that underwent a laparoscopic 
cholecystectomy from May 1, 2013 to December 31, 2014.   
The inclusion criteria for this project included patients within the ages of 18 to 65, 
a BMI greater than 30, and who underwent an elective laparoscopic cholecystectomy 
during the specified dates.  Exclusion criteria include patients with a known allergy to 
acetaminophen, patients who are currently pregnant, patients with severe hepatic 
impairment, severe acute liver disease, chronic alcoholism/opioid use, chronic 
malnutrition, severe hypovolemia, severe renal impairment, or patients who underwent an 
emergent laparoscopic cholecystectomy.   
The sampling frame consisted of 1109 PENs, along with (a) case date, (b) date of 
birth, (c) surgery type (scheduled or emergency), and (d) surgery description.  From the 
list of 1109 patients, the following patients were automatically excluded: (a) 261 older 
than 65 years old, (b) 4 younger than 18 years old, (c) 95 emergent procedures, (d) 30 
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with additional procedures, (e) 24 that converted to an open procedure, and (f) 1 which 
was aborted.  Therefore, 694 charts audited for inclusion and exclusion criteria.  The 
following patients were also excluded from the study: (a) 264 with BMI less than 30, (b) 
13 for chronic opioid use, (c) 3 pregnant, (d) 36 with ESRD, (e) 29 with liver disease, (f) 
5 with pancreatitis, (g) 1 because the file was restricted, and (h) 27 had a PCA pump 
ordered for postoperative pain.  Consequently, this left 316 patient charts available for the 
study.   
The sampling frame of 316 PENs were entered into a spreadsheet, and separated 
into those who received IV acetaminophen (Group T) and those who did not receive IV 
acetaminophen (Group NT).  Group T included 128 PENs, and Group NT included 188.  
The 128 included in Group T were divided by 40, and every third PEN was included in 
the study.  Group NT included 188 and was divided by 40, and every fourth PEN was 
included in the study.  Group T includes subjects who received 1 gram of IV 
acetaminophen during the preoperative period, and Group NT includes subjects who did 
not receive IV acetaminophen while undergoing laparoscopic cholecystectomy.   
After the systematic sampling of the PENs eligible for incision was complete, the 
EMR system was accessed for chart reviews.  The DCF, created by the researcher, was 
utilized during this process.  A patient identification number (PIN) was assigned to each 
subject and included three different aspects.  The first aspect of the PIN was the 
designated group, T or NT, and indicates if the patient was administered IV 
acetaminophen (T) in the preoperative period.  The second aspect of the PIN was 01-40 
and indicates the number of the subject in that group.  The last portion of the PIN was the 
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last three digits of the patient account number in order to ensure that patient’s data was 
not duplicated in the study. 
Target Outcomes 
The desired goal of this capstone project was to determine if obese patients who 
underwent a laparoscopic cholecystectomy required less opioid narcotics in the PACU if 
IV acetaminophen was administered in the preoperative period.  A retrospective chart 
review was performed.  After the data were analyzed from the retrospective chart review, 
a poster presentation and a white paper proposal was developed in order to attempt a 
change in practice for the obese population. 
Barriers 
Barriers to implementing a practice change in the clinical setting are vast, and 
include educational, economic, and motivational factors.  To facilitate a practice change 
related to the administration of IV acetaminophen in the obese population, education 
regarding the differences in pharmacodynamics and pharmacokinetics in these patients 
need to be reinforced.  Economic buy-in and motivation are important and necessary for 
the medical facility to allow IV acetaminophen to be administered in obese patients, 
which is addressed in the cost-benefit analysis. 
Interdisciplinary collaboration is vital to any clinical setting in order to overcome 
barriers for practice change.  Interdisciplinary collaboration can be developed by 
respecting the knowledge and expertise of other team members, asking for input from 
other team members, and communicating “effectively by utilizing active listening, 
compassion, and empathy” (Chism, 2013c, p. 76).  Gardner (2005) added, for effective 
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collaboration to take place, one must learn to value and manage diversity, cultivate 
constructive conflict resolution skills, and understand that collaboration is a journey. 
Research Strategies 
Using the PICO (population/intervention/comparison/outcome) question structure, 
the following research question was developed: Did IV acetaminophen reduce opioid 
administration for postoperative pain in obese patients who underwent a laparoscopic 
cholecystectomy?  The research method carried out for this capstone used a retrospective, 
comparison, quantitative study.  A retrospective study was chosen because both the 
proposed intervention and the proposed outcome have already occurred (Grove, Burns, & 
Gray, 2013).  
Methods 
Once the sample for each group was established, data were collected from the 
preoperative record, including: (a) age; (b) BMI; (c) gender; and (d) ASA classification.  
The ethnicity of the patient was found in the history and physical report generated by the 
surgeon.  The electronic medication administration record (eMAR) was evaluated for the 
time IV acetaminophen was administered, if given.  The data gathered from the 
anesthesia record included: (a) anesthesia start time; (b) time in the PACU; (c) anesthesia 
end time; and (d) the time admitted to the PACU.  The PACU nursing notes were 
analyzed and pertinent data obtained for any events that took place in PACU.  Data were 
gathered from the eMAR during the postoperative period that included the administration 
amount and time of hydromorphone.  Confidentiality of patient information was 
sustained during the study.  Patient data were collected so that subjects cannot be 
identified, directly or indirectly. 
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Some items on the DCF created by the researcher in the planning stage were not 
collected and not needed for statistical analysis.  Procedure date, height, weight, current 
medications, and personal medical history (PMH) were reviewed for verification of that 
subject meeting the study criteria.  Other data not needed for this study includes: (a) 
surgeon, (b) previous surgeries, (c) chest radiograph (CXR), (d) electrocardiograph 
(EKG), (e) mallampati classification (MP), (f) past anesthetic complications, (g) beta 
blocker (BB) administration, and (h) abnormal finding on preoperative assessment.  
Airway data, including (a) direct laryngoscopy (DL) information; (b) size and depth of 
the endotracheal tube (ETT); and (c) extubation information was not necessary for this 
study.  Intraoperative adverse events, vital signs (VS), train of four (TOF), intravenous 
fluid (IVF) administration, and estimated blood loss (EBL) data was also unnecessary for 
this study.  Time to ambulation and pain scores were not documented and therefore 
unavailable to obtain. 
After the data were gathered from the selected PENs, it was entered into a 
spreadsheet and coded for analysis in SPSS software.  The first column was the PINs and 
the corresponding data in each particular row.  The second column indicated whether that 
patient received IV acetaminophen (T) or did not receive IV acetaminophen (NT).   
The next column listed the patient’s age in years, then gender (0 = female, 1 = male). 
Another column contained the patient’s BMI, and another their smoking status (0 = no 
smoking, 1 = smoker, and 2 = former smoker).  The variables coded in minutes included: 
(a) total anesthesia time, (b) total PACU time, (c) total LOS, and (d) time from 
administration of IV acetaminophen to surgery start when appropriate.  Additional 
variables include: (a) ASA, (b) amount of hydromorphone given in the PACU and for the 
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total LOS in mg, (c) adverse events that occurred in PACU (0 = none, 1 = decreased 
oxygen (O2) saturation less than 90%, 2 = nausea, 3 = nausea and vomiting (N/V), and 4 
= decreased O2 saturation and N/V), and (d) if the patient was discharged (d/c) home or 
admitted for observation after leaving PACU (0 = discharged home, 1 = admitted).  See 
Table 3 for patient demographics for both groups and the total sample. 
Statistical Analysis 
The independent group t-test was utilized for this capstone project.  “The t-test 
analyzes the size of the difference between the means of two groups while taking into 
account the sample size and the spread of the scores across the possible range of scores 
(i.e., the standard deviation)” (Brown, 2014, p. 179-180).  The independent group t-test 
was used to compare multiple variables between Group T and Group NT, including (a) 
total anesthesia time; (b) total amount of hydromorphone administered in PACU and total 
LOS; (c) total PACU time; (d) total LOS; and (e) if the patient was discharged home or 
admitted. 
After the data were analyzed, a white paper proposal was prepared and 
disseminated to key stakeholders at the medical facility.  A white paper proposal is used 
to advocate a solution to a particular problem (The Writing Lab, The OWL at Purdue, & 
Purdue University, 2010).  A practice change was also attempted through a poster 
presentation and manuscript submission to a peer-reviewed journal.  Poster presentations 
provide another venue for distributing evidence-based material to a professional 
audience, who can in turn implement the practice change within their healthcare 
institution (Betz, Smith, Melnyk, & Rickey, 2011).  Submission of research for 
publication is imperative since “it provides a peer review of the researcher’s work,” and it 
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“allows networking to occur with individuals who have similar research interests” (Terry, 
2012, p. 181). 
Significance and Implications 
This capstone project determined if IV acetaminophen reduced the amount of 
opioid narcotics needed for postoperative pain in obese patients who underwent a 
laparoscopic cholecystectomy.  The obese population has an increased risk of anesthetic 
complications during the perioperative period due to the physiologic changes associated 
with their body habitus.  These risks are compounded by the administration of opioids in 
the postoperative period.  Although the incidence of respiratory depression due to opioid 
administration is rare, 0.5% with a range of 0.2 to 2%, it is classified as a sentinel event, 
and can result in severe morbidity or mortality (Dahan et al., 2013).  Postoperative pain 
has serious implications on the healing process, and the anesthesia provider is charged 
with the task to control this complication. 
Conclusion 
The following research question was employed for this capstone project: ‘In 
obese patients undergoing laparoscopic cholecystectomy, does IV acetaminophen reduce 
opioid use for postoperative pain?’  A retrospective chart review was performed with a 
convenience sample.  The data were evaluated to determine any significant results 
between the groups who received IV acetaminophen and the control group.  The results 
of this study will potentially decrease opioid administration in the postoperative period 
for the obese surgical patient. 
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CHAPTER IV 
ANALYSIS OF DATA 
This capstone project reflects chart reviews of 80 EMRs, 40 in Group T and 40 in 
Group NT.  The confidence interval (CI) for this sample size is +/- 4.79 with 95% 
confidence level, calculated by the Confidence Interval Calculator for Proportions 
(McCallum Layton, 2015).  All participants in Group T received 1 gram IV 
acetaminophen in the preoperative period only, however, no additional doses were 
administered.  Midazolam was administered to each patient in the preoperative period, 
and ranged from 1 to 5 mg.  Fentanyl was given intraoperatively to blunt the airway 
response and pain control as needed, and varied from 100 micrograms (mcg) to 300 mcg. 
This project utilized independent samples t-tests to assess the differences in 
principal outcomes between Group T and Group NT.  The t-tests were executed using 
SPSS by the statistician and Microsoft Excel for Mac 2011 (version 14.4.0) by the 
researcher.  Results that were considered to be significant were those with a p value less 
than 0.05 or 95%.  A computer program, G*Power 3.1 created by Faul, Erdfelder, 
Buchner, & Lang (2009) was utilized by the researcher for all post-hoc power analysis.  
Pain assessments were not documented at regular intervals; therefore, no data were 
collected on pain scores.  Naloxone was not administered to any of the sample 
participants. 
Discussion of Results 
The sample population for this capstone project was predominantly Caucasian 
females.  Of the 80 subjects, 25 (31.25%) were male, and 55 (68.75%) female.  Group T 
comprised 35% (14) male and 65% (26) female, whereas Group NT contained 27.5% 
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(11) male and 72.5% (29) female.  The Caucasian ethnicity was the most prominent (58 
subjects, 72.5%) for the total sample, Group T (29 subjects, 70%), and Group NT (30 
subjects, 75%).  The majority of the total participants in this study consisted of 
nonsmokers (59 participants, 73.75%).  Both Group T and Group NT were composed 
primarily of patients categorized as ASA 2 (28 participants, 70%; 29 participants, 73%).  
See Table 3 for patient demographics. 
Table 3 
Patient demographics 
 
Group T  
(n = 40) 
Group NT  
(n=40)  
Total  
(N = 80) 
Gender    
Male 14 (35%) 11 (27.5%) 25 (31.25%) 
Female 26 (65%) 29 (72.5%) 55 (68.75%) 
Ethnicity    
 African American  9 (22.5%) 8 (20%) 19 (23.75%) 
 Caucasian 28 (70%) 30 (75%) 58 (72.5%) 
 Hispanic 1 (2.5%) 2 (5%) 3 (3.75%) 
Smoking status    
 Nonsmoker 27 (67.5%) 31 (80%) 59 (73.75%) 
 Smoker 9 (22.5%) 6 (15%) 15 (18.8%) 
 Former smoker 4 (10%) 2 (5%) 6 (7.5%) 
ASA Classification 
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Table 3 (continued). 
 ASA 1 2 (5%) 4 (10%) 6 (7.5%) 
 ASA 2 28 (70%) 29 (73%) 57 (71%) 
 ASA 3 10 (25%) 7 (18%) 17 (21%) 
An independent-samples t-test was conducted to compare patient age for Group T 
and Group NT.  There was a significant difference found in the scores for Group T 
(M=44.93, SD=11.58) and Group NT (M=38.95, SD=11.44); t (78) =2.29, p=0.03.  These 
results suggest that the age of the participating subjects may have an impact on the 
factors related to other variables.  
An independent-samples t-test was conducted to compare the difference in BMI 
between Group T and Group NT.  There was not a significant difference in the BMI for 
Group T (M=38.49, SD=5.51) and Group NT (M=40.61, SD=7.14); t(78)= -1.49, p=0.19.  
These results suggest that the difference in BMI between Group T and Group NT do not 
affect the results of other variables between the two groups. 
The time from IV acetaminophen to surgical cut in Group T had a wide range, 34 
to 484 minutes, with the mean being 137.475 minutes.  The manufacturer does not 
require or suggest a specific administration time for the purpose of possibly reducing the 
amount of opioid use for postoperative pain.  However, the clinician must remember that 
the onset of analgesia of IV acetaminophen is less than 10 minutes, and the maximum 
analgesia is attained in 15 minutes (Golembiewski, 2011).   
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Table 4 
Age, BMI, and IV acetaminophen times 
 Group T  
(n = 40) 
Group NT  
(n=40)  
Total  
(N = 80) 
Age 
 Min 22 19 19 
 Max 62 60 62 
 Mean 44.93 38.95 41.94 
 SD 11.58 11.44 11.89 
 P value 0.03   
BMI    
 Min 30.29 31.42 30.29 
 Max 56.14 63.08 63.08 
 Mean 38.49 40.61 39.55 
 SD 5.44 7.05 6.39 
 P value 0.19   
Time from IV acetaminophen to surgery start 
 Min 34   
 Max 484   
 Mean 137.48   
 SD 94.98   
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An independent-samples t-test was conducted to compare total anesthesia time for 
Group T and Group NT.  There was no significant difference in the scores for Group T 
(M=83.85, SD=12.3) and Group NT (M=90.9, SD=21.54); t(78)= -1.78, p=0.0965.  
These results suggest that IV acetaminophen has no direct effect on the amount of time 
that the patient is anesthetized. 
An independent-samples t-test was conducted to compare the amount of 
hydromorphone administered in the PACU for Group T and Group NT.  There was a 
significant difference in the amount of hydromorphone administered for Group T 
(M=0.63, SD=0.61) and Group NT (M=1.00, SD=0.70); t (78)= -2.54, p=0.02.  These 
results suggest that IV acetaminophen has a direct effect on the amount of 
hydromorphone the patient receives in PACU for postoperative pain relief. 
An independent-samples t-test was preformed to compare total PACU time for 
Group T and Group NT.  No significant difference was found in the PACU times for 
Group T (M=68.93, SD=42.02) and Group NT (M=55.68, SD=23.24); t(78)= 1.75, 
p=0.09.  These results suggest that IV acetaminophen has no direct effect on the amount 
of time that the patient stays in PACU.  However, patients who experienced any adverse 
side effects were admitted to the medical facility, which affected the total LOS for these 
patients. 
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Table 5 
Total anesthesia time, hydromorphone given in PACU, and Total PACU time 
 Group T  
(n = 40) 
Group NT  
(n=40)  
Total  
(N = 80) 
    
Total anesthesia time    
Min 66 43 43 
Max 117 156 156 
Mean 83.85 90.9 87.38 
SD 12.30 21.54 17.89 
P value 0.10   
Hydromorphone given in PACU   
Min 0 0 0 
Max 2 3 3 
Mean 0.63 1.00 0.81 
SD 0.61 0.70 0.68 
P value 0.02   
Total PACU time    
Min 27 24 24 
Max 163 129 163 
Mean 68.93 55.68 62.3 
SD 41.49 22.95 34.17 
P value 0.09   
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Adverse events in the postoperative period can result in an unintended extended 
LOS, reduction or cessation of reimbursement, and decreased patient satisfaction.  The 
most common adverse event in this study for both Group T and Group NT during and 
after PACU was nausea.  Of the subjects in Group T, 50% did not have any adverse 
events in the PACU, and 70% did not have any adverse events after PACU.  See table 8 
for adverse events during and after PACU.  Surprisingly, 2 subjects in Group T 
experienced decreased O2 saturation in PACU, whereas 0 patients in Group NT 
encountered this adverse event.  Another unexpected discovery in this study was 15% of 
Group T encountered nausea and vomiting (N/V) during PACU, whereas 2.5% of Group 
NT encountered N/V in PACU.  The incidence of all measured adverse events in both 
groups decreased after PACU, except nausea and N/V in Group NT. 
The most common adverse event in this study was PONV.  Similarly, a 
randomized prospective study by Memis, et. al. (2010) found that administration of IV 
acetaminophen every 6 hours in addition to meperidine significantly reduced PONV 
compared to placebo and meperidine.  In contrast, Konstantatos, et. al. (2012) did not 
find a significant difference in the instance of PONV between IV acetaminophen group, 
oral (PO) acetaminophen group, and placebo.  A study that compared IV acetaminophen 
to placebo in adults undergoing tonsillectomy also found no significant difference in 
adverse events (Atef & Fawaz, 2008).  Additional literature similarly reported no 
significant difference in ORADEs with the addition of IV acetaminophen compared to 
placebo (Tzortzopoulou et. al, 2011). 
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Table 6 
Adverse events during and after PACU 
 Group T  
(n = 40) 
Group NT  
(n=40)  
Total  
(N = 80) 
Adverse events in PACU   
 No adverse events 20 (50%) 11 (27.5%) 31 (38.75%) 
 Decreased O2 Sat 2 (5%) 0 2 (2.5%) 
 Nausea 11 (27.5%) 28 (70%) 39 (48.75%) 
 N/V 6 (15%) 1 (2.5%) 7 (8.75%) 
 Decreased O2 Sat and 
N/V 
1 (2.5%) 0 (0%) 1 (1.25%) 
Adverse events after PACU 
 No adverse events 28 (70%) 24 (60%) 52 (65%) 
 Decreased O2 Sat 0  0 0 
 Nausea 7 (17.5%) 11 (27.5%) 18 (22.5%) 
 N/V 5 (12.5%) 5 (12.5%) 10 (12.5%) 
 Decreased O2 Sat and 
N/V 
0 0 0 
This retrospective chart review assessed the discharge status of patients in both 
Group T and Group NT.  A majority of the patients in Group T were discharged home 
(33, 82.5%), whereas only half of the patients in Group NT were discharged home (20, 
50%).  This discharge status is an important factor in the total cost for the patient and the 
healthcare facility. 
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An independent-samples t-test was conducted to compare the amount of 
hydromorphone administered during the total LOS for Group T and Group NT.  There 
was a significant difference in the amount of hydromorphone administered during the 
total LOS for Group T (M=1.08, SD=0.89) and Group NT (M=2.21, SD=2.19); t (78)= -
2.98, p=0.005.  These results suggest that one dose of IV acetaminophen in the 
preoperative period reduces the amount of hydromorphone for postoperative pain relief 
for the entire LOS.   
An independent-samples t-test was conducted to compare the total LOS for Group 
T and Group NT.  There was a significant difference in the total LOS for Group T 
(M=704.63, SD=768.42) and Group NT (M=1237.90, SD=928.38); t (78)= -81.88, 
p=0.007.  These results suggest that one dose of IV acetaminophen in the preoperative 
period reduces the average LOS. 
Table 7 
Discharge status, total hydromorphone, and total LOS 
 Group T  
(n = 40) 
Group NT  
(n=40)  
Total  
(N = 80) 
Discharge status  
Home 33 (82.5%) 20 (50%) 53 (66.25%) 
Inpatient 7 (17.5%) 20 (50%) 27 (33.75%) 
Total hydromorphone    
Min 0 0 0 
Max 3.8 11 11 
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Table 7 (continued).    
    
Mean 1.08 2.21 1.65 
SD 0.89 2.19 1.77 
P value 0.005   
Total LOS    
 Min 54 249 54 
 Max 3673 4071 4071 
 Mean 704.625 1237.9 971.26 
 SD 758.75 916.70 882.68 
 P value 0.007   
Cost Analysis 
Cost effectiveness is an important aspect of any sustainable business, as well as 
healthcare facility.  Although the price of IV acetaminophen was increased tremendously, 
this study noted that the total mean cost for Group T is significantly lower than Group 
NT.  This price difference is due to the number of patients that were admitted for 
inpatient status.  Reducing the amount of opioids administered to obese patients in the 
postoperative period decreases the risk of ORADEs, which increase the total LOS. 
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Table 8 
Cost analysis 
 Group T  
(n = 40) 
Group NT  
(n=40)  
Cost of PACU $950 $950 
Number of Patients 40 40 
Total Cost for the group $38,000 $38,000 
Cost of Ofirmev $34  
 Number of Patients 40  
 Total Cost for the group $1,360  
Discharge status  
 Home 33 20 
 Inpatient 7 20 
Cost of Admission $912 $912 
Total Cost for the group $6,384 $18,240 
Total Cost for the group $45,744 $56,240 
Mean Cost for the group $1,143.6 $1,406 
Conclusion 
The main goal of this retrospective quantitative study was to determine if IV 
acetaminophen reduced the amount of opioid administration for postoperative pain in the 
PACU for obese patients who underwent a laparoscopic cholecystectomy.  The subjects 
that formed Group T were found to use significantly less amounts of opioids in the 
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PACU period (p = 0.02), as well as during the total LOS (p = 0.005).  Smith and Hoefling 
(2014) also found that IV acetaminophen did reduce the amount of opioids administered 
compared to the control group, using morphine equivalents (ME) (p=0.015).  Another 
study found that the addition of IV acetaminophen in addition to meperidine reduced the 
meperidine consumption in the postoperative period (76.75 +/- 18.2 mg) compared to 
meperidine and placebo (198 +/- 66.4 mg) (Memis, et. al., 2010). 
Wininger, et. al. (2010) found that IV acetaminophen provided the patients with 
statistically significant analgesia during the postoperative period compared to placebo.  
Atef and Fawaz (2008) also discovered that IV acetaminophen notably decreased the 
amount of opioid consumption compared to placebo.  Another study found that the group 
that received IV acetaminophen required 30% less opioids over 4 hours when compared 
to placebo (Tzortzopoulou et. al., 2011).  The effectiveness of IV acetaminophen 
combined with an effective patient-nurse relationship, as indicated by the theory of goal 
attainment, could reduce postoperative pain in obese patients, and therefore, decrease 
opioid administration during this period. 
Total PACU time was not found to be significant between Group T and Group NT 
in this capstone project.  The facility cost of a PACU stay at the selected medical center is 
$950, regardless of the time spent in recovery.  However, if the patient must be admitted 
for overnight stay, the cost to the medical facility is an additional $912 for a non-
telemetry bed.  The total LOS between Group T and Group NT was found to be 
significant (p = 0.007).  The difference in the total LOS produced a drastic price 
difference between these two groups, which is the bottom line in all businesses.  This 
study noted a difference between the two groups in the discharge status of the patients.  
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Thirty-three (82.5%) participants in Group T were discharged home, compared to 20 
(50%) in Group NT.  Konstantatos, et. al. (2012) did not show a substantial difference in 
the length of PACU stay or the total LOS with the addition of IV acetaminophen.  
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CHAPTER V 
SUMMARY 
The purpose of this capstone project was to determine if IV acetaminophen 
decreased opioid use for postoperative pain in obese patients who underwent a 
laparoscopic cholecystectomy.  Postoperative pain is an anticipated and feared outcome 
of any surgery.  Uncontrolled postoperative pain can impede the healing process, along 
with other disastrous outcomes.  Opioids are commonly used for pain control in the 
postoperative period.  However, opioids have side effects that could be amplified in the 
obese patient.  This capstone project noted that the administration of IV acetaminophen in 
the preoperative period does reduce the amount of opioids needed for postoperative pain 
control in obese patients undergoing laparoscopic cholecystectomy.  This study also 
indicated that the addition of IV acetaminophen correlated with a decrease in total LOS 
and the occurrence of ORADEs. 
Limitations 
There were limitations to this capstone project.  The method of this study was a 
retrospective chart review, which could have more bias than a prospective study.   
The researcher could not compare pain scores between groups because none were not 
documented.  No physician or nurse’s notes were present to explain why the patient was 
admitted compared to being discharged home.   
Benefits 
There were also benefits of completing a retrospective chart review instead of a 
prospective study.  The information was readily available for the researcher at any time, 
making data collection less complicated.  No funding was needed for this project.   
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There were also no additional work or resources required from the medical facility.  The 
results of this study show that IV acetaminophen decreases opioid consumption in the 
postoperative period and the entire LOS.  This project also found that IV acetaminophen 
minimizes the total LOS, which significantly decreases the healthcare costs for this 
patient population. 
Future Directions 
This capstone project could be expounded upon in the future.  Additional studies 
could be done on a larger scale involving other surgical procedures.  A prospective study 
would provide more complete data for the researcher.  Another aspect of IV 
acetaminophen administration that could be researched is the time of administration 
compared to the pain scores in the postoperative period.  Another avenue pertaining to IV 
acetaminophen decreasing postoperative pain is to examine the effects of one dose 
compared to one dose every six hours. 
Conclusion 
Postoperative pain is an unfortunate side effect of any surgery and must be 
managed for adequate healing.  This study examined IV acetaminophen given in the 
preoperative period compared to opioid use for pain control in the postoperative period, 
and did find a difference.  Opioids are the most common medication administered in the 
postoperative period for pain control, but can cause adverse occurrences.  There was also 
a difference between the total LOS and the use of IV acetaminophen.  In today’s 
economy, healthcare should be patient-centered and cost effective.  This capstone project 
has shown that the administration of IV acetaminophen decreases postoperative pain, 
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opioid use, and the total LOS.  Even with a dramatic price increase, IV acetaminophen 
should be utilized to provide exceptional, cost-effective care. 
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APPENDIX A 
LITERATURE REVIEW TABLE 
 Author(s), Date Purpose or Research 
Question(s) 
Research Design/ 
Level of Evidence 
Sampling Method, 
Size, and Setting 
Results Strengths Weaknesses Implications for 
Practice 
         
1. Memis, Inal, 
Kavalci, Sezer, and 
Sut, 2010 
To assess pain relief 
effectiveness, side 
effects, and time to 
extubation of ICU 
patients after major 
surgery receiving IV 
paracetamol 
(acetaminophen) in 
addition to IV 
meperidine 
Quantitative-single 
randomized 
controlled trial 
 
Level of Evidence: 
2 
40 adult ICU 
patients after major 
abdominal or pelvic 
surgery, who were 
anticipated to need 
24-hour 
postoperative 
sedation and 
ventilation. 
Pts were 
randomized into 2 
groups using sealed 
envelopes. Group 1 
received IV 
meperidine only, 
and group 2 
received IV 
paracetamol and IV 
meperidine. 
 
BPS and pain scores 
are notably lower in 
group 2 at 24 hours 
(P<0.5). In group 2, 
postoperative 
meperidine 
requirements (76.75 
+/- 18.2 mg vs. 198 
+/- 66.4 mg) and 
extubation time 
(64.3 +/- 40.6 min 
vs. 204.5 +/- 112.7 
min) were lower 
than in group 1 
(P<0.1). PONV and 
sedation scores were 
also considerably 
lower in group 2 
when compared 
with group 1 
(P<0.5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
The findings were 
consistent with 
various other studies 
regarding the use of 
acetaminophen in 
combination with 
morphine in the 
management of 
postoperative 
analgesia and 
decreasing the 
amount of morphine 
required. 
No similar clinical 
studies were found 
of meperidine/ 
paracetamol IV 
regarding extubation 
time after major 
surgery when the 
patients were in 
ICU. 
The factors that 
cause PONV cannot 
be controlled in 
order to achieve 
significant results. 
IV acetaminophen, 
in addition to 
meperidine 
enhances postop 
pain relief, sedation, 
and time to 
extubation in adult 
ICU patients after 
major abdominal or 
pelvic surgery when 
compared with 
meperidine only. 
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2. Wininger, Miller, 
Minkowitz, Royal, 
Ang, Breitmeyer, 
and Singla, 2010 
To assess the safety 
and analgesic 
efficiency of 2 doses 
of IV acetaminophen 
in patients after 
laparoscopic 
abdominal 
procedures in a 24 
hour period, when 
compared to placebo. 
Double-blind, 
placebo-controlled, 
parallel-group study 
 
Level of evidence: 2 
244 adult post 
surgical patients 
from 17 sites 
randomized into 4 
different groups: IV 
acetaminophen 1000 
mg [100 mL] q6h; 
IV acetaminophen 
650 mg [65 mL] 
q4h; IV placebo 100 
mL q6h; or IV 
placebo 65 mL q4h), 
over a 24 hour 
period. 
 
Both groups of IV 
acetaminophen 
showed significantly 
lower pain scores 
when compared to 
placebo. 
 
Multiple sites in the 
US participated in 
this study. 
The results of this 
study are consistent 
with similar studies. 
 
 
There was an 
allocation error after 
subject 109 (of 244 
enrolled) that 
affected 
randomization.  
 
Many patients had 
to remain inpatients, 
unnecessarily to 
participate in the 
study. 
 
There were study 
design errors that 
may have 
contributed to the 
lack of statistical 
significance for time 
to rescue and opioid 
consumption. 
IV acetaminophen 
is effective for 
controlling 
postoperative pain 
in this patient 
population. 
This study showed 
no significant 
difference in the 
safety profile of IV 
acetaminophen and 
placebo. 
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Level of Evidence 
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Size, and Setting 
Results Strengths Weaknesses Implications for 
Practice 
         
3. Konstantatos, 
Smith, and Angliss, 
2012 
This article 
investigated whether 
intraoperative IV 
acetaminophen has 
the potential to 
reduce pain 
after ambulatory 
surgery and reduce 
time to discharge 
from the PACU and 
hospital. 
Prospective 
randomized, double-
blind clinical trial 
 
Level of evidence: 2 
 
A total of 142 
patients undergoing 
ambulatory surgery 
were randomized to 
pre and 
postoperative 
placebo (50), IV 
operative and 
postoperative oral 
acetaminophen (49), 
and pre and 
postoperative oral 
acetaminophen (48) 
 
The primary end 
point; visual 
analogue scale mean 
pain intensity over 
24 hours after 
completion of 
surgery, was not 
considerably 
different between 
the 3 groups, control 
group 2.0 (1.6), 
mean (SD), (IV) 
acetaminophen 
group 2.1 (1.9) and 
oral acetaminophen 
group 2.1 (1.6); 
(p=0.93). Time to 
fitness for discharge 
from the 
postoperative care 
unit (p=0.77) and 
time to fitness for 
discharge from 
hospital (p=0.27) 
also did not vary 
significantly 
between the three 
groups. 
 
 
 
 
 
 
 
 
 
 
 
 
142 total patients 
participated 
3 arm study 
Baseline patient and 
clinical 
characteristics were 
similar in the three 
groups 
Anesthetists had the 
option of combining 
fentanyl with 
morphine for 
analgesia and 
surgeons allowed to 
use local anesthetic 
infiltration if 
desired. 
The study was 
limited to one 
ambulatory surgery 
center with a study 
population of 
predominantly 
young healthy 
males. 
In this setting, IV 
acetaminophen 
administered 
intraoperative did 
not provide 
significant pain 
relief or a reduction 
in discharge times 
compared to oral 
acetaminophen or 
placebo. 
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Research Design/ 
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Size, and Setting 
Results Strengths Weaknesses Implications for 
Practice 
         
4. Atef and Fawaz, 
2008) 
To assess the 
analgesic efficacy, 
safety, and the opioid 
sparing effect of IV 
paracetamol 
(Perfalgan) after 
elective 
tonsillectomy in 
adults. 
Prospective 
randomized, double-
blind placebo-
controlled study 
 
Level of evidence: 1 
 
76 adult patients, 
ages 16-40 at Ain 
Shams University 
hospital who 
underwent an 
elective 
tonsillectomy. 
 
Patients were 
randomized into 2 
groups using a 
computer program 
randomization to 
either the 
acetaminophen 
(Perfalgan) or the 
placebo group. A 
nurse not involved 
in the study 
prepared the 
infusion for 
administration to 
ensure blindness.  
 
 
 
 
 
 
 
In the paracetamol 
group, 29% of 
patients received 
rescue analgesics 
compared to the 
placebo group, 
100% of patients.  
Pain scores were 
significantly higher 
in the placebo 
group. 
 
Baseline patient and 
clinical 
characteristics were 
similar in both 
groups 
Induction 
medications were the 
same for all patients 
and based on mg/kg 
basis. 
The study was 
limited to one 
medical facility. 
The setting was not 
described for those 
wanting to duplicate 
the study. 
IV paracetamol 
given every 6 hours 
on postoperative 
day 1 provided 
greater pain relief 
compared to 
placebo for these 
patients.  
IV paracetamol 
produced no 
significant adverse 
events. 
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Results Strengths Weaknesses Implications for 
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5. Anand et al. 
(2013) 
To compare the 
effectiveness of 
pain relief after 
administration of 
1g IV 
acetaminophen or 
30mg IV ketorolac 
for patients who 
underwent a 
parathyroidectomy 
 
Parallel, 
randomized, 
double blind, 
comparative 
study 
 
Level of 
evidence: 1 
 
180 patients, 18 years 
and older scheduled for 
outpatient 
parathyroidectomy. 
Setting: level 1 trauma 
hospital. 
Patients were 
randomized to a 
blinded administration 
of either IV 
acetaminophen 1 g or 
ketorolac 30 mg intra- 
operatively. Upon 
arrival and before 
premedication, baseline 
pain scores were 
documented in all 
patients. VAS scores 
were assessed every 15 
minutes in the PACU 
until discharge by 
blinded personnel. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Overall mean postoperative 
VAS scores were not 
significantly different between 
the 2 treatment groups 
(p=0.07). Rescue opioids were 
required by 3 patients in the 
ketorolac group compared to 9 
patients in the acetaminophen 
group. However, total opioid 
consumption was not 
significant between groups (p = 
0.13). The overall incidence of 
rescue opioid administration, 
vomiting, headache, muscular 
pain, dizziness, and drowsiness 
were not significantly different 
between the 2 groups. 
Induction 
medications were 
the same for all 
patients and based 
on mg/kg basis. 
Large sample size – 
180 patients, 90 in 
each group. 
Patient 
demographics and 
surgical time were 
similar in both 
groups 
The study was 
limited to one 
medical facility. 
Acetaminophen 1 g 
IV was 
administered at the 
beginning of the 
procedure or 30 mg 
IV ketorolac 15 
minutes before the 
end of the surgery. 
The peak onset of 
acetaminophen is 
<30 minutes and 
duration of action 
is 4-6 hours. The 
peak onset of 
ketorolac is 10 
minutes and 
duration of action 
is 6-8 hours. 
Both groups 
provided adequate 
pain relief. 
However, the IV 
ketorolac group 
had significantly 
lower pain scores 
at later time 
intervals (at 45, 60, 
and 75 minutes) 
and also had lower 
occurrences of 
PONV. 
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6. Smith and Hoefling 
(2014) 
To evaluate pain 
scores, opioid 
consumption, and 
ORADEs in spinal 
surgery patients after 
receiving IV 
acetaminophen. 
Retrospective 
analysis 
 
Level of Evidence: 
3 
The EMR of 68 
spinal surgery 
patients were 
assessed. The 
acetaminophen 
group (n=34) 
received at least 1 
dose pre or 
postoperatively of 
IV acetaminophen 
and the control 
group (n=34) did not 
receive 
acetaminophen but 
had similar 
characteristics as 
group A.  
The acetaminophen 
group (11.3 mg ME) 
used significantly 
less opioids that the 
control group (20.6 
mg ME) (p=0.015). 
There was no 
significant 
difference between 
the 2 groups in pain 
scores and 
ORADEs. 
Respiratory 
depression that 
required naloxone 
administration 
occurred in 1 patient 
in the control group. 
The mean patient 
demographics were 
similar in both 
groups 
 
Retrospective 
analysis – cannot 
control variables. 
 
The setting was not 
described for those 
wanting to duplicate 
the study. 
 
The average surgery 
time was longer in 
the acetaminophen 
group (216.0, SD 
114.4) compared to 
the control group 
(187.5, SD 93.9) 
(P=0.264). 
 
Inconsistent 
documentation of 
pain scores. 
 
Possible bias in the 
selection process, of 
the matched control 
group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IV acetaminophen 
can be administered 
as an effective 
adjunct analgesic in 
this patient 
population to reduce 
opioid use, but not 
necessarily reduce 
the prevalence of 
ORADEs or pain 
scores. 
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7. Tzortzopoulou et 
al., 2011 
The purpose of this 
study was to assess 
the efficacy and 
safety of IV 
propacetamol for the 
treatment of 
postoperative pain in 
adults and children. 
Systemic review  
 
Level of Evidence: 
1 
36 Randomized, 
double-blind, 
controlled single 
dose clinical trials 
(3896 participants) 
of IV propacetamol 
for acute 
postoperative pain 
in adults or children 
were included. Two 
addition reviews 
evaluated the risk of 
bias and extracted 
data. 
Of the 3896 
patients, 37% of 
those receiving IV 
propacetamol had at 
least 50% pain relief 
over 4 hours 
compared to 16% in 
the placebo group. 
The proportion of 
participants in IV 
propacetamol group 
experiencing at least 
50% pain relief 
diminished over 6 
hours. Participants 
that received IV 
propacetamol 
required 30% less 
opioid over 4 hours 
than the placebo 
group. No 
significant 
difference was 
found in ORADEs 
between the 2 
groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The 2 reviewers 
impartially evaluated 
the risk of bias of all 
included studies, 
using a domain-
based assessment. 
 
Only randomized 
studies were 
included, which 
reduced the potential 
for bias. 
 
Large number of 
studies (36) and 
therefore participants 
(3896) 
All age groups were 
included. 
 
The results included 
studies involving 
different surgical 
procedures. 
 
The possibility of 
bias using 
unpublished trials 
showing no benefit 
of IV propacetamol 
or IV paracetamol 
over placebo may 
exist. 
 
Both formulations 
were showed to be 
associated with 
fewer ORADEs. 
 
IV propacetamol 
had a higher 
occurrence of pain 
on infusion than 
both placebo and IV 
paracetamol. 
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8. Singla et al. 
(2014) 
This study 
determined the 
efficacy of 
postoperative pain 
control and safety 
of IV 
acetaminophen for 
patients who 
underwent 
arthroplasty 
Evaluation of 2 
double-blind, 
parallel-group, 
multicenter, 
randomized, 
placebo-controlled 
clinical trials 
 
Level of Evidence: 
2 
Total 130 modified intent-to-
treat (mITT) patients, 
November 2003-September 
2004. 
Study 1: single-dose efficacy, 
n=69, 11 medical sites in the 
U.S. (IV acetaminophen, 
n=35; placebo, n=34) 
undergoing total hip 
arthroplasty. 
Study 2: repeated-dose 
efficacy, n=61 (IV 
acetaminophen, n=30; 
placebo, n=31). 
21 days preop – screening w/ 
consent, H&P, labs, and 
education on using a PCA 
and pain scales. 
All pts were anesthetized 
using either general, spinal, 
or epidural anesthesia. A 
PCA was started in PACU. 
Morphine 2mg was available 
for rescue analgesia. PCA 
was interrupted 16 hours after 
surgery. Once the pt’s VAS 
was at least 45mm, either IV 
acetaminophen or IV placebo 
was administered (T0). Pts 
were asked to wait 30 mins  
after receiving the infusion 
before using PCA. Pain 
responses were assessed in 
regular increments 
 
 
 
 
 
Mean pain intensity 
differences (PID) of 
IV acetaminophen 
were significantly 
higher than the 
control group 
(P<0.5). 
VAS scores were 
consistently lower in 
IV acetaminophen 
than the control 
group. 
IV acetaminophen 
decreased rescue 
opioid requirements 
for up to 6 hours in 
study 1 and up to 4 
hours in study 2. 
Mean time for 
rescue analgesia for 
IV acetaminophen 
was 4.72 compared 
to placebo 1.4 in 
study 1, and >4 and 
1.25, respectfully in 
study 2. 
Both studies had 
similar patient 
populations, study 
design, and 
methodologies. 
 
These 2 studies 
provided 
administration of IV 
acetaminophen 
postop day 1 to 
reduce variability 
that may have been 
present due to the 
type of anesthetic. 
 
Particulate matter 
and altered pH found 
in the placebo 
caused early 
termination of both 
studies. 
 
Converted to 
modified intent-to-
treat (mITT) 
 
Study 1: n reduced 
from 140 to 69. 
 
Study 2: n reduced 
from 230 to 61. 
 
Patients did not 
receive the same 
type of anesthesia. 
 
IV acetaminophen 
was not initiated 
until after surgery. 
 
Limited collection of 
samples. 
Both studies showed 
that IV 
acetaminophen is 
effective and safe 
for postoperative 
pain relief when 
used in this patient 
population 
 
IV acetaminophen 
significantly 
improved analgesia, 
and decreased 
opioid consumption 
in more than 50% of 
patients when 
compared with 
placebo. 
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9. Ong, Seymour, 
Lirk, and 
Merry, 2010 
This study 
assessed the 
effectiveness of 
combining 
paracetamol and 
an NSAID 
versus either 
drug alone in 
different acute 
pain models. 
Qualitative 
Systematic 
Review 
 
Level of 
Evidence: 5 
A systematic literature 
search of Medline, 
Embase, Cumulative 
Index to Nursing and 
Allied Health Literature, 
and PubMed covering 
the period from January 
1988 to June 2009 was 
performed to identify 
randomized controlled 
trials in humans that 
specifically compared 
combinations of 
paracetamol with 
various NSAIDs versus 
at least 1 of these 
constituent drugs. 
Identified studies were 
stratified into 2 groups: 
paracetamol/NSAID 
combinations versus 
paracetamol or NSAIDs. 
We analyzed pain 
intensity scores and 
supplemental analgesic 
requirements as primary 
outcome measures. In 
addition, each study was 
graded for quality using 
a validated scale. 
 
 
 
 
 
 
 
 
Twenty-one human studies 
enrolling 1909 patients were 
analyzed. The NSAIDs used were 
ibuprofen (n=6), diclofenac 
(n=8), ketoprofen (n=3), 
ketorolac (n=1), aspirin (n=1), 
tenoxicam (n=1), and rofecoxib 
(n=1). The combination of 
paracetamol and NSAID was 
more effective than paracetamol 
or NSAID alone in 85% and 64% 
of relevant studies, respectively. 
The pain intensity and analgesic 
supplementation was 35.0%+/-
10.9% and 38.8% +/-13.1% 
lesser, respectively, in the 
positive studies for the 
combination versus paracetamol 
group, and 37.7% +/- 26.6% and 
31.3% +/- 13.4% lesser, 
respectively, in the positive 
studies for the combination 
versus the NSAID group. No 
statistical difference in median 
quality scores was found between 
experimental groups. 
The subgroup 
analysis by surgical 
model and NSAID 
type confirms the 
overall results and 
further strengthens 
the conclusion. This 
conclusion is 
consistent with many 
previous expert 
reviews that 
recommend the use 
of combination 
analgesics 
 
Limitations of our 
study include its 
qualitative approach 
and the wide range 
of acute pain models 
included in the 
studies reviewed.  
 
 
This review 
suggests that 
combining 
paracetamol and an 
NSAID confers 
additional analgesic 
efficacy over either 
drug alone. 
 
There are some 
potential 
disadvantages in 
combining NSAIDs 
and paracetamol. 
A combination may 
be disadvantageous 
when individual 
drugs are 
specifically suited to 
a patient’s 
symptoms (e.g., 
when only the 
antipyretic action of 
paracetamol is 
required for fever). 
Combining 
analgesics may 
increase the 
incidence of adverse 
effects. 
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10. Macario and 
Royal, 2010 
To evaluate 
analgesic 
outcomes in the 
postoperative 
period after 
administration 
of IV 
acetaminophen 
in adults 
Systematic 
review 
 
Level of 
evidence: 1 
The authors 
investigated 
prospective, 
randomized, 
controlled trials 
(RCTs) from 
January 2000 
to January 
2010 in 
Medline and 
the Cochrane 
library 
databases to 
compare IV 
acetaminophen 
and an active 
comparator or 
placebo. 22 
studies were 
included for a 
total of 1,464 
subjects.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 of 8 comparative studies, 
including IV parecoxib [n = 3 
studies], IV metamizol [n = 4], oral 
ibuprofen [n = 1], IV 
acetaminophen had no significant 
difference in postoperative pain 
relief. 
12 of 14 studies found a significant 
difference in analgesia from the 
administration of IV acetaminophen 
compared to placebo.  
10 of 14 studies found patients who 
received IV acetaminophen required 
less opioids, a lower percentage of 
patients needing rescue opioids, or a 
longer period of time to the first 
rescue needed. 
 
In aggregate, these data suggest that 
IV acetaminophen is an efficient 
analgesic for a assortment of 
patients and a variety of surgeries. 
This study’s 
findings were 
consistant with 
other related 
articles. 
 
Small participant size in the 
majority of the studies. 
There were various analgesic 
interventions among the 
studies, including nerve 
blocks. 
The studies used various 
systems for documenting the 
variables. 
Publication bias also cannot 
be discounted.  
 
The IV 
acetaminophen has a 
faster onset than the 
oral or rectal 
administration; 
therefore, the IV 
formulation would be 
preferred for treating 
acute pain in surgical 
patients. 
 
The selected RCTs in 
this study indicated 
that IV acetaminophen 
is an efficient 
postoperative 
analgesic for a variety 
of surgical 
procedures. 
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11. Lewis, Gunta, 
Mitchell, and 
Bobay, 2012 
The purpose of this 
study was to 
evaluate different 
analgesic 
approaches, group 
1 included patients 
receiving a 
multimodal 
approach and 
group 2 did not.  
Retrospective 
chart review 
 
Level of 
evidence: 3 
A convenience sample of 
patients undergoing TKA 
from 2009-2010 was 
obtained. The control 
group included 45 patients 
from 2009 and the 
multimodal group included 
66 patients from 2010. A 
data collection tool, 
developed by the 
researchers was used to 
gather data. A staff RN 
was trained by the 
researchers and gathered 
data using the data 
collection form. 
The multimodal protocol 
included the use of 
oxycontin 20mg PO, 
acetaminophen 1g PO, 
celecoxib 400mg PO, 
gabapentin 600mg PO, 
ondansetron 4mg PO, 
naropin 0.2% of femoral 
continuous PNB, 
oxycodone 5mg, 10mg and 
20mg PO, and ketorolac 
15mg IV. 
 
 
 
 
 
 
 
 
 
 
 
The researchers 
discovered lower 
PACU pain scores, 
a decreased 
probability of 
PONV, and shorter 
LOS in the 
multimodal group 
versus the control 
group. 
The multimodal 
and control group 
subjects were of 
similar age and 
the samples were 
not statistically 
different based on 
gender. 
Retrospective 
analysis – cannot 
control variables 
and cannot 
determine causal 
relationships. 
 
The setting was 
not described for 
those wanting to 
duplicate the 
study. 
 
Limited to 1 
medical facility 
and 1 surgeon. 
 
Retrospective 
study  
Well-controlled postoperative 
pain provides more favorable 
outcomes and possibly a 
reduction in LOS for this 
patient population. 
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12. Xiromeritis, 
Kalogiannidis
, 
Papadopoulos
, Prapas, and 
Prapas, 2011 
The purpose 
of this study 
is to assess 
postoperative 
pain when 
using a set of 
multimodal 
guidelines for 
females 
undergoing 
uterine 
fibroid 
surgery. 
Prospective, 
randomized 
trail 
 
Level of 
evidence: 1 
92 patients undergoing 
laparoscopic myomectomy 
and laparoscopic assisted 
myomectomy were 
randomized into 2 groups 
using sealed envelopes: 
group I received the 
multimodal analgesic 
protocol and group 2 did 
not. 
The VAS scale was used to 
assess postoperative pain 2 
and 8 hours postoperative. 
The multimodal protocol 
included the following 
medications: 
dexamethasone 8 mg IV, 
local anesthetic injected at 
the trocar sites, 
ondansetron 4 mg IV, a 
mixture of diclofenac 75 
mg and paracetamol 600 
mg IM. In the 
postoperative period, both 
groups received 
paracetamol 1 g q 8 hours, 
diclofenac 50 mg 
suppository BID PRN. 
The mean VAS at 2 and 8 h 
postoperatively was 
significantly lower in the 
multimodal group compared to 
the control group (2 h 
postoperatively: 4.7 ± 0.7 vs 7.1 
± 0.9, P < 0.0001; 8 h 
postoperatively: 2±0.6 vs 
4.5±0.8, P<0.0001). 
Peristalsis returned earlier in 
the multimodal group compared 
to the control group (10.1 ± 2.7 
vs 23 ± 1.6 h, P < 0.0001). The 
multimodal group compared to 
the control group had reduced 
hours in the hospital, indicating 
a faster recovery time (11 ± 5 
vs 26.8 ± 5.8 h, P < 0.0001). All 
but 1 woman in the multimodal 
group were discharged between 
6 and 16 h postoperatively. One 
woman in the multimodal group 
was discharged 44 h 
postoperatively, due to a mild 
fever and late return of bowel 
peristalsis. All patients in the 
control group were discharged 
at least 20 h after surgery. No 
significant difference was found 
in the amount of time for return 
of full activity between the 2 
groups. Either group had no 
ORADEs. 
 
 
 
 
 
The patient’s 
characteristics in the two 
groups were similar, 
except for the mean age. 
 
The LOS, pain scores, 
incidences of PONV, and 
ORADEs were all 
assessed by physicians 
who were not aware of the 
study. The physicians 
used the PADSS 
discharge criteria, which 
limited possible bias. 
 
A significant 
difference in mean 
age was found 
(35.7 ± 5.7 vs 33.4 
± 4.7, P < 0.04).  
 
A multimodal 
approach, including 
different nonopioid 
analgesics and 
peripheral nerve 
blocks are generally 
safe and can assist 
with postoperative 
pain control in this 
patient population. 
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Research 
Question(s) 
Research 
Design/ Level 
of Evidence 
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13. Minkowitz, 
Gruschkus, 
Shah, and 
Raiu, 2014 
The purpose of 
this study is to 
evaluate the 
opioid-related 
adverse drug 
events 
(ORADEs) that 
were reported 
within a large 
healthcare 
facility. 
Retrospective 
cohort study 
 
Level of 
evidence: 3 
The EMRs from 
11 hospitals were 
analyzed with a 
total of 6,285 
patients, 18 years 
and older, that had 
an inpatient 
surgical procedure 
in 2010. The 
EMRs were 
examined from 
admission date to 
postdischarge day 
30. The amount of 
opioids 
administered and 
the frequency of 
adverse drug 
events (ADEs) 
were documented. 
Outcomes after  
Of the 6,285 patients, 99.8% 
were administered opioids in 
the postoperative period, 
11.0% (n=689) of those 
patients experienced 
ORADE, including GI 
ADEs (6.3%, n=396), 
Respiratory (2.9%, n=182), 
GU (1.5%, n=94), CNS 
(0.6%, n=38), and other 
(0.9%, n=57). In the overall 
population, patients 65 years 
of age or older were twice as 
likely to have an ADE 
compared with younger 
patients. In the overall 
population, postoperative 
opioid use was significantly 
associated with ADE risk. 
The mean healthcare cost for 
those that experienced an 
ADE compared to those who 
did not were $29,782 vs 
$16,045. The LOS was 
higher in those patients who 
experienced an ADE than 
those that did not (10.0, 5.5 
days). Thirty day 
readmission rates in patients 
who experienced an ADE 
were 71%. The mortality 
rates of patients who 
experienced an ADE (3.4%) 
was higher than those who 
did not (1.5%). 
 
 
 
 
Described 
setting 
adequately. 
 
Identified risk 
factors 
associated with 
ADEs, along 
with healthcare 
costs associated 
with ADEs. 
Retrospective analysis – 
cannot control variables 
and can not determine 
causal relationships. 
 
Of the final study 
population 72.1% 
(n=4,522) were female. 
The frequency of ADEs 
may have been higher 
than reported if 
documentation was not 
adequate. 
 
The study lacks data 
regarding BMI, opioid 
dosages and morphine 
equivalences, home 
medications, the duration 
of surgery, and the need 
for mechanical 
ventilation. 
 
The examined database 
only captured 11 
hospitals, therefore the 
readmission rates could 
be under estimated.  
 
This study found that patients 
with multiple risk factors for 
ORADEs were more likely to 
have higher hospital costs due 
to the extended LOS, and 
higher readmission rates 
compared to patients with 
fewer risk factors. 
Results of this study 
demonstrate that 
postoperative opioid use 
occurred in nearly all patient 
cases evaluated and that 
approximately 11% of the 
patients experienced an ADE, 
with GI events being the most 
common. 
 
Factors found to be associated 
with increased ADE risk 
included demo- graphic 
characteristics, such as older 
age and male sex, and clinical 
factors, such as prior opioid 
use, COPD, cardiac 
dysrhythmia, regional 
enteritis, diverticulitis, and 
ulcerative colitis. 
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Research Design/ 
Level of Evidence 
Sampling Method, 
Size, and Setting 
Results Strengths Weaknesses Implications for 
Practice 
         
14. Oderda et al., 2007 The purpose of this 
study was to research 
the impact of 
ORADEs on hospital 
LOS in adult surgical 
patients. 
Retrospective 
matched cohort 
study 
 
Level of evidence: 3 
Surgical patients 
treated at LDS 
Hospital in Salt 
Lake City from 
January 1, 1998, to 
December 31, 2003, 
were included.  The 
ORADE group 
included 741 
participants, 17 
years and older. 
Each ORADE 
participant was 
matched with 15 
control cases with 
similar 
demographics and 
characteristics 
(n=10,116). 
Patients 
experiencing 
ORADEs had 
significantly 
increased total mean 
hospital costs (7.4% 
increase, p < 0.001) 
and increased 
median LOS (10.3% 
increase, p < 0.001) 
when compared to 
the control group.  
The ORADE and the 
control group had 
statistically similar 
demographics and 
characteristics  
Retrospective 
analysis – cannot 
control variables and 
can not determine 
causal relationships. 
The study did not 
use morphine-
equivalent doses.  
 
ORADEs may have 
been underestimated 
due to using a 
computer-prompted 
method of 
surveillance, and 
bias was not 
controlled.  
 
Cost data may not 
be generalizable due 
to the small 
geographic area of 
the study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Postoperative ADEs 
were found to 
increase LOS and 
therefore increase 
cost.  
 
These ADEs were 
found to transpire 
more frequently in 
patients who require 
more opioids for 
postoperative pain 
control. 
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15. Pizzi et al., 2012 
 
This study examined 
if ORADEs had an 
impact on 
postoperative 
hospital LOS. 
Retrospective chart 
review 
 
Level of evidence: 3 
A stratified, random 
sample of 402 
patients, age 18 or 
older who 
underwent 
orthopedic spine, 
hip, knee, or 
shoulder surgery 
during 2007. The 
EMRs were 
reviewed and data 
collected by 3 
trained abstractors. 
The data collected 
included patient 
demographics, LOS, 
drug therapy, and 
ORADEs. The dose 
of all opioids were 
converted to MEs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Over half (54.2%) 
of the participants 
experienced at least 
1 adverse effect. 
Nearly 1:5 (18.4%) 
of the patients 
experienced 2 
adverse effects and 
7.2% experienced 3 
or more. There was 
no significant 
difference between 
surgery types and 
the incidence of 
adverse events. N/V 
was the most 
common adverse 
effect (36.1%).  
Included 4 different 
procedures – spine, 
hip, knee, and 
shoulder surgery. 
Retrospective 
analysis – cannot 
control variables and 
cannot determine 
causal relationships. 
 
Limited to 2 
academic medical 
facilities. 
 
The frequency of 
ADEs may have 
been higher than 
reported if 
documentation was 
not adequate. 
ORADEs, such as 
Constipation, 
PONV, and 
disorientation 
resulted in increased 
in LOS.  
 
There is a need for 
further examination 
of risk factors of 
ORADEs, which 
effects LOS. 
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16. Eckstrand et al., 
2009 
 
This study examined 
the opioid-related 
over-sedation and 
respiratory 
depression after 
naloxone 
administration 
Retrospective, 
cross-sectional 
study 
 
Level of evidence:  
3 
Patients that were 
administered 
naloxone (n=419) in 
the perioperative 
period were 
identified using 
computerized 
surveillance. The 
participants were of 
those that had 
surgery at Duke 
University Hospital 
from 10/15/2007-
10/15/2008.  
419 cases of 
perioperative 
naloxone 
administration were 
found, of which, 101 
were given 
postoperatively and 
69 were documented 
as ADEs yielding a 
rate of 1.89 
ADEs/1000. The 
ADEs increased by 
22.7% when the 
surveillance was 
expanded into 
perioperative period. 
The researchers 
found that 11 of the 
participants had a 
history of over-
sedation. Out of 
those 11, 9 received 
intraoperative 
naloxone, and 2 
received naloxone in 
the PACU. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Described setting 
adequately. 
 
Retrospective 
analysis – cannot 
control variables and 
can not determine 
causal relationships. 
 
The computerized 
surveillance system 
could only detect 
naloxone 
administration if it 
was properly 
documented into the 
EMR. 
 
This computerized 
surveillance system 
is not readily 
available for other 
medical facilities. 
 
The administration 
of naloxone during 
the intraoperative 
period was not 
examined. 
Computerized 
surveillance systems 
may be a very 
useful tool to any 
medical facility to 
detect rare, but fatal 
ADEs.  
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APPENDIX B 
 
SWOT ANALYSIS 
 
Strengths Weaknesses 
 Retrospective chart review 
 No additional costs or added workload for the 
selected clinical site 
 Incomplete or inadequate documentation 
 Cannot control variables as with a prospective study 
Opportunities Threats 
 Change in practice within the selected medical 
facility 
 Change in practice in other medical facilities after 
dissemination 
 IV acetaminophen does not reduce postoperative 
pain in the selected patient population 
 The costs outweighs the benefits of IV 
acetaminophen 
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APPENDIX C 
DNP ESSENTIALS 
DNP Essentials Clinical Implications 
DNP Essentials I – Scientific underpinnings for practice King’s Theory of Goal Attainment utilizes the communication 
and interactions between the patient and the nurse in order for 
the patient to achieve their healthcare goals. The utilization of 
pathophysiology, pharmacology, anatomy, and physiology is 
essential to providing excellent patient care. 
DNP Essentials II – Organizational and systems leadership for 
quality improvement and systems thinking 
The administration of IV acetaminophen may improve 
postoperative pain without the negative side effects of multiple 
doses of opioids.  A practice change will likely be established 
to improve patient safety and satisfaction. 
DNP Essentials III – Clinical scholarship and analytical 
methods for evidence-based practice 
This capstone project assesses the methods currently used to 
prevent postoperative pain in obese patients.  After these 
methods are critiqued, new guidelines for postoperative pain 
prevention will be established for the obese patient. 
DNP Essentials IV – Information systems or technology and 
patient care technology for the improvement and transformation 
of health care 
Performing a retrospective chart review, patient data will be 
extracted from their EMR and protected to avoid ethical and 
legal issues.  Other electronic databases will be utilized for the 
review of literature, industry standards, and other pertinent 
information dealing with laparoscopic cholecystectomy in the 
obese patient, postoperative pain in the obese patient, opioid 
administration in the obese patient, and IV acetaminophen for 
the reduction of postoperative pain. 
DNP Essentials V – Healthcare policy for advocacy in 
healthcare 
If the assumptions of this capstone project prove true, 
advocacy for a practice change will be implemented for the 
reduction in postoperative pain in the obese patient after a 
laparoscopic cholecystectomy, and the reduction of opioids in 
this population.  This will improve patient safety and patient 
satisfaction, as well as patient outcomes. 
DNP Essentials VI – Interprofessional collaboration for 
improving patient and population health outcomes 
Interdisciplinary collaboration can be developed by respecting 
the knowledge and expertise of other team members; asking 
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for input from other team members; and communicating 
effectively by utilizing active listening, compassion, and 
empathy.  For effective collaboration to take place, one must 
learn to value and manage diversity, cultivate constructive 
conflict resolution skills, and understand that collaboration is a 
journey.  Communication is also an essential component 
between the nurse and the patient in order to achieve the 
patient’s health and wellness goals. 
DNP Essentials VII – Clinical prevention and population health 
for improving the nation’s health 
The administration of excessive opioids produces harmful side 
effects, especially in the obese patient.  These adverse side 
effects could cause respiratory depression and detrimental 
effects on the patient’s health and postoperative recovery.  This 
project will evaluate the use of IV acetaminophen and if opioid 
administration is reduced in the postoperative period, which 
could potentially improve the outcomes for this population. 
DNP Essentials VIII – Advanced nursing practice Communication throughout the perioperative period is crucial 
for any surgical procedure in order to provide the desired 
outcomes for that patient.  This communication should be 
continued during the postoperative period so that the patient 
receives optimal care.  Minimizing the use of opioids in PACU 
in a patient, who has a low tolerance to these medications as 
evidence by their reaction during induction of anesthesia, is 
vital to their recovery.  This information should always be 
communicated to the PACU nurse that will be caring for that 
patient.  The use of IV acetaminophen will reduce 
postoperative pain and the quantity of opioids required to 
manage pain.  This will improve patient outcomes and decrease 
the number of adverse events during the postoperative period. 
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APPENDIX D 
LOGIC MODEL 
 
Inputs 
 
Outputs  
Outcomes -- Impact 
 
Activities Participation 
 
Short Medium Long 
Time 
 
Technology 
 Review and 
assess 
records 
CRNAs 
 
Anesthesiologists 
 
Hospitals 
 
Outpatient surgery 
centers 
 
 The incidence of 
postoperative pain 
will decrease in 
obese patients 
undergoing 
laparoscopic 
cholecystectomy 
when given IV 
acetaminophen 
 
Learning 
 
Attitudes 
 
Awareness 
 
Opinions 
 
The need for 
opioid use will be 
reduced in obese 
patients 
undergoing 
laparoscopic 
cholecystectomy 
with the reduction 
of IV 
acetaminophen. 
 
Action 
 
Practice  
 
Decision-making 
 
Policies 
The time to 
ambulation and to 
discharge will be 
reduced in obese 
patients 
undergoing 
laparoscopic 
cholecystectomy 
with the reduction 
of IV 
acetaminophen. 
 
Conditions 
 
Social  
 
Economic  
 
 
Assumptions 
 
External Factors 
The administration of IV acetaminophen 
will decrease postoperative pain in obese 
patients undergoing laparoscopic 
cholecystectomy. 
Improper documentation of administration time of IV acetaminophen, pain 
score, and opioid administration. 
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APPENDIX E 
CITI TRAINING 
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APPENDIX G 
LETTER OF SUPPORT FROM MEDICAL FACILITY 
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APPENDIX H 
LETTER OF SUPPORT FROM USM 
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APPENDIX I 
MEDICAL FACILITY IRB APPROVAL LETTER 
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APPENDIX J 
USM IRB APPROVAL LETTER 
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APPENDIX K 
DATA COLLECTION FORM 
Identification # ________ Procedure Date  
__/__/___ 
Surgeon _____________ 
Age  [_______] Sex  M  / F Ht  [_____]   Wt  
[______] 
BMI  [___]  Smoker Y / N 
Ethnicity  _____________ No Ofirmev / Ofirmev administered  @ _____________ 
Current Medications  ____________________________________________________ 
______________________________________________________________________ 
PMH  ________________________________________________________________ 
______________________________________________________________________ 
Previous Surgeries  ______________________________________________________ 
______________________________________________________________________ 
CXR on  ___________ - _________________________________________________ 
EKG on  ___________ - _________________________________________________ 
ASA  ______  MP  ______ Past anesthetic complications  _____________________ 
BBlocker  ___________________________________  
Abnormal finding on preop  _______________________________________________ 
Preop meds (other than Ofirmev)  __________________________________________ 
Anes Start  _____________ Anes End  ____________ Total Anes  ____________ 
Surgery Start  ___________ Surgery End  _________ Total Surgery  __________ 
DL x ___  Grade ____ view Size ____ ETT @ ______ Blade  _________________ 
Intraoperative: 
Time Medication Dose Train of Four Vital signs 
     
     
     
     
     
     
     
     
Extubation:  Awake / Deep / NA Intraoperative Adverse events:  _________________ 
_______________________________________________________________________ 
IVF type:  _____________ Total IVF:  ______ mL   EBL  ______ mL 
PACU time in:  _________ PACU time out:  _____ D/C Home / Inpatient 
Time to ambulation:  _____ Adverse events in PACU:  ________________________ 
_______________________________________________________________________ 
Pain score Mins in PACU BP HR RR SpO2 Temp Medication Dose 
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APPENDIX L 
 
PROJECTED TIMETABLE 
 
Capstone proposal to chair/committee November 30, 2014 
Defend Capstone proposal December 10, 2014 
IRB Submission December 20, 2014 
IRB Approval January 30, 2015 
Review charts for patients who underwent 
an elective laparoscopic cholecystectomy 
between May 1, 2013 to December 31, 
2014 
February 1, 2015 to May 15, 2015 
Rough draft on final document July 15, 2015 
Oral defense of Capstone September 1, 2015 
Submit hard copy of Capstone to Graduate 
reader for proofing 
September 2015 
Submit final copy to Graduate reader October 2015 
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APPENDIX M 
WHITE PAPER PROPOSAL 
BACKGROUND:  The management of postoperative pain is essential to many aspects of 
the healing process after an invasive surgical procedure.  The opioid class of pain 
medication has and continues to be the drug of choice for the relief of pain in the 
perioperative setting due to their effectiveness, but these medications have numerous side 
effects that could cause morbidity or even mortality (Casati & Putzu, 2004).  In addition 
to the potential adverse pharmacodynamic effects of opioid consumption, the 
physiological and pathophysiological alterations associated with obesity, pose an 
increased risk for developing adverse events in the postoperative period in the presence 
of opioid administration (Nagelhout, 2014b).   
PURPOSE:  The purpose of this capstone project was to determine if intravenous (IV) 
acetaminophen reduces the amount of opioid administration for postoperative pain in the 
post anesthesia care unit (PACU) in obese patients who underwent a laparoscopic 
cholecystectomy.  
METHODS:  This retrospective study consisted of 80 chart reviews and examined if IV 
acetaminophen reduced opioid consumption in the postoperative period in obese patients 
who underwent a laparoscopic cholecystectomy.  The inclusion criterion comprised 
patients within the ages of 18 to 65, a body mass index (BMI) greater than 30, and that 
underwent a laparoscopic cholecystectomy at the designated medical facility.  Exclusion 
criteria included patients with a known allergy to acetaminophen; severe hepatic 
impairment, chronic alcoholism or use of opioids, and malnutrition; severe hypovolemia, 
or renal impairment. 
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RESULTS OF DATA:  Independent-samples t-tests were conducted to conclude the 
following:   
 IV acetaminophen decreases the amount of hydromorphone the patient receives in 
PACU for postoperative pain relief; Group T (M=0.63, SD=0.61) and Group NT 
(M=1.00, SD=0.70); t (78)= -2.54, p=0.02.  The amount of hydromorphone 
dispensed for the total LOS was also decreased by the administration of IV 
acetaminophen; Group T (M=1.08, SD=0.89) and Group NT (M=2.21, SD=2.19); 
t (78)= -2.98, p=0.005. 
 The majority of the patients in Group T were discharged (d/c) home (33, 82.5%), 
whereas only half of the patients in Group NT were discharged home (20, 50%).  
This discharge status is an important factor in the total cost for the patient and the 
healthcare facility.   
 The average LOS is reduced with the administration of 1 dose of IV 
acetaminophen in the preoperative period; Group T (M=704.63, SD=768.42) and 
Group NT (M=1237.90, SD=928.38); t (78)= -81.88, p=0.007.   
 Although the price of IV acetaminophen was increased tremendously, this study 
shows that the total mean cost for Group T is significantly lower than Group NT.  
This price difference is due to the number of patients that were admitted for 
inpatient status.  See cost analysis table. 
 There was no significant difference between Group T and Group NT in the:  
o Total anesthesia time 
o Total PACU time. 
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Cost analysis 
   
 Group T  
(n = 40) 
Group NT  
(n=40)  
   
   
Cost of PACU $950 $950 
Number of Patients 40 40 
Total Cost for the group $38,000 $38,000 
Cost of Ofirmev $34  
 Number of Patients 40  
 Total Cost for the group $1,360  
Discharge status  
 Home 33 20 
 Inpatient 7 20 
Cost of Admission $912 $912 
Total Cost for the group $6,384 $18,240 
Total Cost for the group $45,744 $56,240 
Mean Cost for the group $1,143.6 $1,406 
CHANGE PROPOSAL:  In order to improve patient safety and reduce healthcare costs, 
we propose all obese patients undergoing a laparoscopic cholecystectomy receive IV 
acetaminophen in the preoperative period unless contraindicated.  Also, limit the amount 
of narcotics administered to this patient population as much as possible to help reduce the 
incidence of adverse events and increased LOS caused by excessive opioids. 
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